rfhg_219231.1

Basic information about the TSS

---

TSS ID: rfhg_219231.1 Species: human Chr: chr20		Start: 31721751 End: 31721822 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3291417,EH38E2106393)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: KJ890762:-396 BT007208:-396 DQ893461:-396 DQ896311:-396 AB464466:-396 KU177938:-396 KU177939:-396 KU177940:-396 GeneID: 598 HGNC/MGI_ID: HGNC:992 UniProt_ID: A0A0S2Z3C5 A0A0S2Z3D2 Nearer transcript ids and distances:

Gene_name: ABALON Gene_symbol: BCL2L1 Gene_synonyms: BCL2L BCLX Bcl-X PPP1R52 bcl-xL bcl-xS Gene_source: HGNC:992

TATA-Box annotation

---

Distance to TSS:	279
Nearest PromoterID:	NR_131907
Entrez ID:	103021294
Nearest Unigene:
Nearest Refseq:	NR_131907
Nearest Ensembl:	ENSG00000281376
Gene Name:	ABALON
Gene Alias:	INXS
Gene Type:	ncRNA
CpG%:	0.070423
GC%:	0.583333
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@BCL2L1 p2@BCL2L1 p3@BCL2L1 p4@BCL2L1 p5@BCL2L1 p6@BCL2L1 p7@BCL2L1 p8@BCL2L1 p9@BCL2L1 p10@BCL2L1
Sample		p1@BCL2L1	p2@BCL2L1	p3@BCL2L1	p4@BCL2L1	p5@BCL2L1	p6@BCL2L1	p7@BCL2L1	p8@BCL2L1	p9@BCL2L1	p10@BCL2L1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	0.58	7.60	0.00	0.39	7.60	0.00	0.00	0.00	0.19	0.39
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	0.81	7.89	0.00	0.40	5.66	0.00	0.00	0.00	0.00	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	0.96	9.45	0.00	0.19	5.21	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	0.21	9.15	0.00	0.21	4.57	0.42	0.00	0.00	0.00	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	0.00	5.85	0.00	0.45	6.52	0.22	0.00	0.22	0.00	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	0.39	9.30	0.00	0.19	3.68	0.58	0.00	0.58	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	1.09	14.60	0.00	0.87	9.37	0.00	0.22	0.00	0.22	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	0.48	10.90	0.24	0.48	6.54	0.24	0.00	0.00	0.00	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	1.28	10.04	0.00	0.64	6.63	0.00	0.00	0.00	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	2.32	12.75	0.00	0.00	11.59	1.16	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	1.21	11.72	0.40	0.40	10.11	0.00	0.00	0.00	0.40	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	1.22	7.32	0.00	0.41	12.20	0.00	0.00	0.00	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	110.26	5.80	20.47	11.61	14.67	7.90	6.77	1.29	3.87	3.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	74.42	4.96	20.30	8.12	12.63	8.87	6.31	1.35	4.66	4.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	100.56	5.93	19.76	10.54	14.93	6.59	6.15	1.10	4.39	2.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	86.51	5.03	17.10	8.30	14.33	7.29	5.03	3.27	4.02	5.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	76.01	2.84	18.35	8.74	11.36	6.77	5.02	2.40	2.84	3.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	70.87	6.33	18.56	8.86	21.09	9.28	3.37	0.84	4.64	5.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	51.18	5.33	22.39	6.93	12.26	10.66	3.73	4.80	3.20	4.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	95.98	4.36	16.55	9.78	15.04	7.82	6.92	1.05	3.31	4.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	86.07	3.74	18.18	10.69	12.96	6.42	5.88	1.74	3.07	3.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	78.54	4.14	19.33	7.77	13.64	8.29	7.42	1.21	3.80	6.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	75.10	4.78	17.32	10.08	14.22	8.27	5.17	2.07	4.52	5.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	76.68	4.13	17.23	8.74	12.38	6.55	5.10	1.21	4.85	2.91
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	84.36	7.22	17.80	5.93	15.48	7.48	3.87	1.55	2.84	3.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	63.30	4.43	20.26	8.55	12.98	8.55	2.85	2.22	2.85	4.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	53.85	4.95	24.18	7.69	13.74	7.69	3.85	1.65	0.55	2.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	81.33	7.07	16.97	10.61	12.97	11.55	6.60	1.41	5.42	4.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	60.09	3.07	14.05	7.91	12.44	4.52	4.04	1.45	4.04	2.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	66.60	4.34	14.48	9.59	10.32	8.14	4.16	1.45	3.26	3.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	57.36	3.98	11.51	10.26	12.56	6.49	3.35	1.26	2.51	3.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	53.14	2.93	12.90	6.25	8.40	7.42	3.91	1.37	2.15	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	37.99	2.11	11.82	7.39	11.82	6.75	2.95	0.42	2.32	4.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	31.67	3.79	12.04	2.47	6.93	10.23	5.77	1.81	1.48	4.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	49.37	3.93	12.15	6.36	10.85	8.04	2.99	0.75	3.37	3.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	56.53	3.83	11.50	7.09	8.24	5.75	3.45	0.77	1.15	3.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	42.51	5.52	8.18	7.36	8.18	8.18	1.64	0.41	1.43	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	38.28	3.02	6.65	9.27	8.66	10.88	3.63	0.60	2.01	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	41.60	4.32	7.02	7.02	5.67	9.45	1.08	1.62	3.51	3.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	21.85	4.80	5.52	6.24	6.96	6.96	1.20	0.48	1.92	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	28.70	4.47	4.94	4.00	6.59	6.82	2.35	1.18	0.71	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	19.62	3.95	5.12	3.81	5.27	9.52	2.34	0.73	2.05	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	26.36	4.22	3.59	5.27	6.96	9.49	2.53	0.63	1.05	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	28.15	4.72	3.32	5.07	8.39	9.97	1.40	1.22	1.22	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	25.70	5.22	4.02	5.82	5.42	10.64	2.41	0.60	1.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	28.15	3.95	2.79	5.58	6.28	10.93	1.40	0.23	1.40	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	21.59	4.56	3.60	6.96	6.96	9.12	1.20	0.24	1.68	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	20.57	3.87	4.77	5.66	6.26	11.33	1.19	0.89	1.49	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	27.05	5.51	3.59	6.70	7.66	9.81	2.39	0.48	1.44	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	21.43	4.85	4.85	4.25	6.67	8.49	1.01	1.21	0.20	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	26.03	4.71	6.97	6.76	4.10	10.66	1.84	1.02	1.43	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	27.57	6.67	6.67	5.56	6.00	10.23	1.33	1.11	0.67	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	13.99	0.00	0.00	13.99	55.97	13.99	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	31.94	5.68	7.81	5.32	9.23	10.29	1.06	0.35	1.06	2.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	32.81	4.31	8.62	9.94	5.96	7.29	1.33	0.66	1.33	4.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	22.65	9.23	5.87	1.68	5.03	32.72	2.52	1.68	0.00	4.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	17.91	8.27	9.18	0.92	1.38	21.13	0.92	0.92	0.92	4.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	48.94	4.54	6.16	8.10	7.13	12.64	2.59	0.32	1.62	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	47.53	2.25	7.71	12.53	6.42	7.71	1.28	0.96	0.96	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	19.17	4.40	7.54	2.51	2.20	26.72	4.40	0.94	1.57	4.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	47.94	3.53	4.23	8.46	5.64	8.46	2.12	2.82	0.71	2.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	48.23	3.93	10.65	7.29	6.73	12.90	2.24	0.56	0.56	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	23.09	3.18	5.57	4.78	0.80	27.07	6.37	0.80	1.59	3.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	19.37	3.06	7.14	3.74	4.08	17.67	2.38	1.36	0.00	4.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	57.51	4.22	7.15	15.92	5.85	13.32	2.60	0.32	0.65	2.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	51.12	4.26	8.87	9.58	4.97	14.20	1.06	0.71	1.06	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	0.00	0.00	16.16	0.00	0.00	48.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	7.90	23.69	0.00	7.90	71.08	15.79	0.00	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	35.59	1.46	9.75	5.85	4.88	19.99	5.85	1.46	0.00	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	31.24	6.94	5.45	6.94	4.46	28.26	3.97	3.47	0.99	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	27.68	2.81	5.16	4.69	7.97	25.80	7.04	1.41	0.94	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	19.21	3.64	4.97	5.96	1.66	23.85	3.64	0.99	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	35.57	3.71	5.26	11.14	4.33	20.42	4.95	1.24	0.62	1.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	44.03	2.14	9.17	9.17	5.20	19.57	4.59	0.00	0.31	2.75
Adipocyte - breast, donor1	11376-118A8	18.37	12.20	23.92	3.01	3.33	1.11	0.79	1.11	1.27	0.95
Adipocyte - breast, donor2	11327-117E4	15.72	9.47	13.48	3.53	0.96	0.32	0.48	1.28	0.80	1.60
Adipocyte - omental, donor1	11473-119C6	18.07	13.36	16.92	4.07	1.78	2.04	0.38	0.64	1.53	1.15
Adipocyte - omental, donor2	11474-119C7	18.69	6.73	7.47	2.24	0.00	0.00	0.00	0.75	0.75	0.75
Adipocyte - omental, donor3	11475-119C8	11.39	12.73	6.36	2.68	1.34	0.33	0.00	0.33	0.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	21.69	7.66	17.86	1.28	1.91	1.28	1.28	1.28	0.00	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	4.40	4.40	2.20	0.00	0.00	0.00	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	27.55	7.23	18.52	5.42	4.52	0.90	2.26	0.90	3.16	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	25.37	10.43	11.64	1.91	2.26	0.35	0.00	0.35	0.17	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	13.30	9.58	5.48	3.13	2.15	0.59	0.39	0.20	0.20	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	8.49	5.66	3.86	2.32	1.03	0.26	0.26	0.26	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	13.10	6.13	6.13	1.67	5.02	0.56	0.28	0.56	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	15.28	6.47	6.47	1.76	1.18	0.59	0.00	0.00	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	7.64	9.81	5.47	1.45	2.41	0.16	0.24	0.00	0.16	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	13.23	5.81	11.94	0.32	1.61	0.65	0.97	0.00	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	10.66	10.13	9.06	2.67	0.00	0.00	0.00	1.60	0.53	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	6.12	12.24	8.90	0.56	1.11	0.00	0.00	0.00	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	4.99	9.15	2.08	2.08	2.08	0.42	0.00	0.42	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	8.29	8.29	9.29	2.76	3.01	1.51	0.25	0.00	0.75	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	11.13	4.91	6.87	0.65	1.64	1.31	0.00	0.00	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	5.48	9.13	3.04	0.61	0.61	0.61	0.61	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	25.86	9.06	9.94	14.59	13.70	11.93	11.05	6.41	3.54	2.43
Alveolar Epithelial Cells, donor2	11590-120G6	65.62	6.81	29.76	17.57	20.80	21.87	15.42	6.81	5.74	7.89
Alveolar Epithelial Cells, donor3	11671-122G6	38.34	4.79	3.59	8.39	4.79	5.99	8.39	4.79	2.40	2.40
Amniotic Epithelial Cells, donor1	11533-120A3	19.79	9.89	6.84	7.74	5.22	3.42	7.74	1.26	1.44	1.08
Amniotic Epithelial Cells, donor2	11613-122A2	30.12	13.39	8.37	3.35	6.69	0.00	3.35	1.67	0.00	3.35
Amniotic Epithelial Cells, donor3	11694-123A2	18.08	9.45	5.96	10.07	4.52	3.08	5.55	3.49	0.82	2.26
Anulus Pulposus Cell, donor1	11248-116E6	28.61	10.87	8.01	6.52	1.83	0.34	0.34	0.23	0.46	0.80
Anulus Pulposus Cell, donor2	11463-119B5	30.37	8.82	7.10	3.92	2.94	0.49	0.24	0.49	0.98	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	16.17	6.74	1.80	3.59	5.39	0.90	2.25	0.90	0.45	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	16.93	5.64	6.08	3.47	2.60	0.87	0.43	0.43	0.00	2.17
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	8.56	4.28	4.28	2.14	2.14	0.00	0.00	2.14	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	14.05	7.77	6.58	2.39	3.29	2.09	0.30	0.60	0.60	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	12.65	5.06	2.53	3.79	1.26	1.26	1.26	2.53	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	13.20	4.62	7.92	3.30	7.92	0.00	0.66	0.00	0.00	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	13.00	6.82	6.17	3.57	3.57	0.97	0.97	0.65	0.32	1.95
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	14.08	6.80	2.91	2.43	3.88	0.49	0.49	0.00	0.97	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.31	2.97	9.50	6.53	6.53	0.59	0.00	0.59	0.00	1.78
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	16.20	8.29	7.53	4.14	5.27	0.38	0.75	0.00	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	15.24	4.35	2.90	4.35	5.08	0.73	0.00	0.00	0.73	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	13.79	5.02	3.76	3.76	2.51	0.00	0.00	0.00	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	12.85	7.58	6.92	6.26	4.78	0.49	0.33	0.82	0.49	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	15.01	12.28	0.00	4.09	5.46	0.00	0.00	0.00	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	11.76	6.48	6.33	3.77	5.73	0.60	0.30	0.90	0.75	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	10.18	5.89	4.82	2.68	4.82	0.54	0.54	0.54	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	13.23	6.23	4.91	3.59	4.16	0.19	0.38	0.76	0.19	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	11.23	5.88	6.68	3.47	3.47	0.80	0.00	0.53	0.80	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	16.58	3.90	1.95	4.88	0.98	0.98	0.00	2.93	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	13.43	5.81	6.30	4.15	4.98	0.33	0.66	0.66	0.33	1.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	15.61	6.00	7.20	6.00	6.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	21.24	7.08	7.08	3.54	7.08	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	14.24	6.69	4.46	4.12	3.77	0.34	0.17	0.34	0.17	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	8.39	4.19	0.00	4.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	13.11	3.88	2.91	1.46	2.91	0.49	0.49	0.00	0.49	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	14.04	4.17	5.31	2.66	4.17	0.38	1.90	1.14	0.00	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	7.27	9.69	1.21	3.63	3.63	0.00	0.00	3.63	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	10.83	3.99	5.70	2.28	4.56	1.71	0.00	0.57	1.14	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	9.62	5.77	7.91	5.77	5.77	0.43	0.64	1.28	0.21	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	12.39	8.52	6.45	3.87	5.16	0.52	0.26	1.55	0.52	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	15.01	6.10	2.82	2.35	5.16	0.47	0.94	1.41	1.41	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	18.97	6.75	6.11	4.18	4.18	0.96	0.00	0.00	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	7.13	6.42	7.85	4.28	2.85	1.43	0.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	10.53	7.60	4.68	5.85	4.09	0.58	0.58	0.00	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	15.96	5.12	5.72	6.32	6.02	1.20	0.00	0.90	0.60	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	22.57	3.56	5.94	7.13	3.56	0.00	0.00	1.19	1.19	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	16.78	6.10	9.15	4.07	4.58	0.51	0.51	0.51	0.51	2.54
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	14.26	5.86	7.39	2.55	3.57	0.51	0.76	0.76	0.51	1.78
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	10.80	3.81	9.53	3.18	3.81	0.00	0.00	0.64	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	19.85	7.77	4.75	4.75	4.75	0.00	0.86	1.29	0.43	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	13.76	5.50	8.04	6.14	6.77	0.85	0.42	0.21	1.06	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	11.31	4.35	6.67	3.77	4.06	0.29	0.00	0.00	0.87	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	22.67	8.50	6.61	3.78	2.83	0.00	0.00	0.94	0.00	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	15.77	5.93	4.58	5.42	4.07	0.17	0.51	1.02	0.68	1.02
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	2.32	4.63	4.63	4.63	0.00	0.00	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	6.34	6.34	0.00	6.34	2.11	0.00	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	9.65	6.00	4.29	3.22	3.22	0.86	1.07	0.64	0.43	0.86
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	12.63	3.01	4.81	3.61	7.82	0.00	0.00	2.41	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	17.50	2.92	2.92	2.19	0.73	0.00	0.00	0.00	0.73	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	10.57	4.14	5.98	4.14	3.68	1.84	0.00	1.38	0.46	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	0.00	10.20	5.10	10.20	5.10	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	7.37	6.36	6.10	5.08	5.08	0.76	0.00	0.76	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	10.12	5.99	3.72	3.72	3.92	0.21	0.00	0.62	0.83	0.83
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	7.34	4.90	3.67	2.75	4.59	0.61	0.31	0.00	0.00	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	9.08	4.78	5.26	5.26	4.30	0.00	0.48	0.00	0.00	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	7.76	6.87	3.77	4.88	4.21	0.44	0.22	0.67	0.00	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	3.05	3.05	3.05	6.10	4.58	1.53	0.00	0.00	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	6.09	3.88	3.32	2.22	2.22	0.00	0.00	0.55	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	9.53	6.09	3.44	2.12	5.03	0.53	0.26	0.53	0.53	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	3.63	6.18	2.54	3.27	4.00	1.45	0.73	0.00	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	31.07	21.86	10.32	11.05	8.60	1.84	0.61	1.47	0.98	0.98
Astrocyte - cerebellum, donor2	11580-120F5	66.07	13.18	16.43	15.58	8.04	1.88	1.54	1.37	1.54	2.23
Astrocyte - cerebellum, donor3	11661-122F5	31.25	16.36	6.29	6.08	6.50	1.05	0.42	1.26	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	18.82	8.71	2.44	5.23	4.88	1.74	0.70	0.35	0.35	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	24.75	9.87	6.15	9.71	10.52	3.07	2.26	1.13	1.29	1.62
Astrocyte - cerebral cortex, donor3	11392-118C6	26.25	10.14	7.01	7.91	5.67	1.19	1.79	1.04	0.75	1.04
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	3.56	13.07	0.57	1.95	15.60	20.99	6.42	2.06	1.03	0.92
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	3.63	15.28	0.00	1.88	18.04	21.05	6.64	3.01	0.50	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	2.05	14.91	0.68	1.02	17.41	16.16	4.21	1.71	0.23	1.25
Basophils, donor1	12241-129G9	6.80	6.80	1.57	1.57	3.14	2.35	0.26	0.26	0.26	0.00
Basophils, donor2	12242-129H1	6.86	7.94	2.16	1.44	3.97	1.80	0.00	0.00	0.00	0.72
Basophils, donor3	12243-129H2	3.67	8.82	1.32	2.06	2.79	0.88	0.15	0.29	0.15	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	12.29	12.94	3.02	7.11	3.45	1.94	1.51	0.22	1.08	0.86
Bronchial Epithelial Cell, donor2	11591-120G7	22.86	7.77	6.40	13.26	6.40	3.20	6.40	0.46	1.37	1.83
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	7.17	7.17	0.00	0.00	0.00	0.00	0.00	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	23.85	11.30	11.93	9.41	8.16	1.26	1.88	0.00	0.00	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	30.36	10.61	9.98	8.11	7.28	2.08	4.99	0.62	1.25	1.66
Bronchial Epithelial Cell, donor6	11461-119B3	32.93	6.68	11.51	5.53	7.37	5.07	8.06	0.46	1.61	1.84
Bronchial Epithelial Cell, donor7	11769-123I5	12.42	7.20	2.88	4.50	2.88	2.70	3.42	0.54	1.08	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	8.24	10.51	2.27	5.46	2.47	1.55	18.14	0.52	0.21	0.52
Burkitt's lymphoma cell line:RAJI	10476-106I8	5.82	17.70	0.93	1.40	4.66	7.45	10.71	0.70	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	5.12	6.40	5.12	2.88	4.16	0.00	0.32	0.32	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00	0.00	10.34	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	3.94	6.20	1.69	1.13	3.38	1.13	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	4.08	5.75	1.48	0.93	3.34	0.74	0.00	0.00	0.19	0.93
CD14+ Monocytes, donor3	11381-118B4	5.27	9.44	1.32	0.66	4.61	0.44	0.00	0.00	0.00	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	14.44	13.02	32.27	3.11	0.85	0.85	0.28	0.85	0.57	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	17.06	7.58	29.19	3.41	1.90	2.27	2.27	0.38	0.00	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	19.40	12.82	29.26	2.30	1.31	0.33	0.66	0.00	0.00	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	1.59	11.85	1.30	1.01	1.88	0.14	0.00	0.29	0.14	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	1.21	4.53	0.60	0.60	2.11	0.00	0.00	0.00	0.60	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	3.08	5.45	0.71	0.24	2.13	0.00	0.00	0.00	0.00	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	1.67	3.85	0.84	0.17	1.84	0.00	0.00	0.33	0.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	0.55	2.76	0.83	0.00	2.21	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	1.98	1.74	1.49	0.99	1.74	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	2.35	2.74	1.37	0.20	1.96	0.00	0.00	0.00	0.20	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	2.31	1.96	1.07	0.53	0.53	0.18	0.00	0.00	0.18	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	1.31	3.92	0.87	1.31	1.74	0.87	0.00	0.44	0.00	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	0.94	3.04	0.94	0.47	0.94	0.00	0.23	0.00	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	1.06	5.28	2.11	0.00	3.17	0.53	0.00	0.53	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	1.11	1.11	3.33	1.11	1.11	1.11	0.00	0.00	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	1.93	5.35	0.74	0.30	1.78	0.00	0.00	0.15	0.30	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	1.00	3.19	1.40	0.40	1.40	0.00	0.00	0.00	0.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	0.42	5.20	1.25	0.00	1.87	0.00	0.00	0.21	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	2.75	2.75	0.69	0.92	2.06	0.23	0.00	0.46	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	0.45	1.58	0.90	0.00	1.81	0.00	0.45	0.00	0.45	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	1.31	1.31	1.75	0.87	1.75	0.00	0.00	0.00	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	5.65	4.57	4.84	2.69	3.50	0.00	0.00	0.27	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	3.49	4.88	1.57	1.05	3.66	0.00	0.00	0.17	0.52	0.70
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	5.05	8.00	2.10	2.95	5.05	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	2.76	0.92	2.94	0.55	1.84	0.18	0.00	0.18	0.55	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	4.58	1.41	2.82	0.00	6.34	1.41	0.35	0.35	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	4.39	0.88	5.26	0.44	4.83	6.14	0.88	0.00	0.00	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	1.39	3.49	1.22	0.87	1.74	0.35	0.00	0.17	0.17	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	0.37	2.23	0.37	0.00	1.49	0.00	0.00	0.00	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	2.37	3.45	0.65	0.43	2.37	0.00	0.00	0.00	0.22	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	3.69	4.09	1.23	1.64	2.05	0.00	0.82	0.82	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	2.78	1.85	1.39	0.23	1.39	2.32	0.23	0.23	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	2.78	2.78	5.80	0.46	2.55	7.19	0.00	0.46	1.16	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	1.74	11.33	0.87	1.09	2.83	0.00	0.00	0.22	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	2.31	9.93	0.46	1.62	2.54	0.00	0.00	0.00	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	0.87	8.66	0.22	1.30	2.60	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	1.56	14.17	1.25	0.47	2.18	0.00	0.00	0.00	0.00	0.78
CD14+CD16- Monocytes, donor2	11799-124C8	2.10	12.40	0.70	0.35	1.75	0.00	0.00	0.00	0.00	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	2.01	15.38	0.22	0.89	1.11	0.00	0.00	0.22	0.22	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	1.02	12.76	0.77	1.02	2.04	0.00	0.00	0.26	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	1.54	13.39	0.88	0.88	2.20	0.00	0.00	0.00	0.00	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	1.89	14.11	1.05	0.21	2.11	0.00	0.00	0.00	0.00	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	4.06	6.10	0.00	2.03	10.16	0.00	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	4.07	8.81	0.00	1.36	6.10	0.00	0.00	1.36	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	0.00	5.18	0.00	1.04	5.18	1.04	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	0.53	7.46	0.00	2.67	10.66	0.00	1.07	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	4.29	12.87	0.54	3.75	5.36	1.07	0.00	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	4.91	9.13	0.00	0.70	6.32	0.00	0.00	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	3.92	12.55	0.78	2.35	7.06	0.00	0.78	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	2.64	6.59	0.00	0.00	5.27	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	0.82	4.11	0.00	0.82	5.75	0.82	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	1.45	5.08	0.00	0.73	7.25	0.73	0.73	0.00	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	2.52	6.06	0.00	0.00	5.05	0.50	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	415.37	71.11	61.01	87.28	43.64	133.34	12.53	98.59	46.87	17.78
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	309.21	53.13	43.15	85.89	49.54	96.68	11.59	72.71	39.95	12.78
CD34+ Progenitors, donor1	11545-120B6	7.03	2.01	4.02	3.01	5.02	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	2.25	0.00	0.56	0.56	3.37	0.00	0.00	0.00	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	13.15	7.52	7.89	6.76	3.38	0.75	0.38	0.75	0.75	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	11.27	9.47	6.76	6.54	4.28	0.45	0.23	0.00	0.00	0.45
CD4+ T Cells, donor1	11225-116C1	2.86	11.07	1.07	1.43	5.36	2.86	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	3.06	4.90	1.22	2.45	11.02	1.84	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	4.57	9.45	1.52	3.35	5.49	1.52	0.30	0.00	0.00	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	6.64	15.31	2.04	3.06	2.81	79.12	1.02	0.26	0.00	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	6.06	14.37	2.02	2.25	4.04	109.83	0.90	1.57	0.00	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	8.34	16.39	2.87	5.17	1.44	106.94	2.30	1.44	0.00	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	3.32	7.59	0.00	1.42	2.84	0.95	0.47	0.00	0.00	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	5.62	7.73	0.70	2.81	2.81	0.70	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	6.59	13.18	0.00	9.89	0.00	6.59	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	11.27	21.53	2.60	4.91	4.48	30.06	0.87	2.31	0.14	1.16
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	12.88	20.34	3.73	5.93	6.61	61.85	2.88	1.19	0.34	2.03
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	12.57	14.35	2.58	4.35	5.64	68.67	0.81	0.97	0.00	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	6.72	6.28	1.34	3.14	4.48	2.24	0.90	0.45	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	6.99	10.83	1.05	2.80	3.84	5.24	1.75	0.00	0.35	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	7.92	10.12	1.32	3.08	3.52	6.60	1.76	0.00	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	9.28	15.60	3.79	3.37	4.22	35.84	0.84	1.69	0.00	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	13.51	23.27	5.40	4.36	5.19	36.57	1.87	1.25	0.21	2.70
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	16.04	26.06	6.68	4.68	4.68	32.41	1.67	1.34	0.33	1.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	2.45	13.87	0.27	1.36	1.90	2.18	0.54	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	3.75	15.01	0.00	2.14	3.22	4.29	0.54	0.00	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	12.55	0.00	0.00	5.38	1.79	0.00	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	12.42	24.85	3.52	4.64	4.45	27.63	0.93	0.56	0.00	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	12.13	25.78	6.50	4.12	3.90	27.51	2.38	1.95	0.22	2.60
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	18.07	26.48	4.62	8.20	5.67	26.90	0.84	0.84	0.21	1.05
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	5.56	5.56	1.01	3.54	1.52	3.03	0.51	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	5.20	13.86	0.43	1.73	2.17	3.47	0.00	0.00	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	7.41	12.64	1.31	4.36	3.05	3.05	0.00	0.00	0.00	2.18
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	8.41	15.84	0.49	5.44	4.45	5.44	0.00	0.00	0.00	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	12.00	16.62	1.85	0.92	9.23	4.62	0.92	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	2.79	9.77	2.79	2.79	5.58	8.37	2.79	0.00	0.00	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	13.29	15.78	3.05	3.32	6.65	8.03	1.11	0.00	0.00	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	11.53	23.07	2.70	3.93	3.44	7.85	0.98	0.25	0.25	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	6.16	18.48	0.00	4.62	7.70	4.62	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	11.46	13.97	4.30	5.01	4.66	6.80	1.43	0.00	0.00	1.79
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	8.31	15.23	2.77	6.92	6.92	12.46	1.38	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	6.88	6.22	2.95	3.60	9.17	5.24	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	9.76	3.00	2.25	2.25	8.26	1.88	0.00	0.00	0.00	1.13
CD8+ T Cells, donor3	11383-118B6	5.05	7.83	1.77	2.52	12.37	1.51	0.50	0.00	0.00	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	1.38	6.42	1.84	0.92	6.88	51.61	0.46	26.84	1.84	2.29
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	1.68	7.91	1.20	1.92	6.23	49.37	0.48	25.88	1.68	4.07
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	1.64	5.75	2.74	0.00	7.11	56.63	0.55	34.75	1.64	6.02
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	3.00	5.10	2.70	0.00	3.90	95.47	0.60	44.13	2.70	5.70
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	1.20	8.40	1.92	0.24	8.16	53.28	0.24	29.52	2.64	2.88
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	2.50	7.28	1.36	0.68	4.55	56.85	0.68	31.38	1.36	2.50
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	3.26	6.30	2.39	0.65	6.08	70.62	0.65	27.81	3.48	1.74
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	2.11	5.53	2.37	1.05	6.05	64.75	0.53	36.85	2.37	3.16
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	2.81	6.33	2.58	0.70	5.86	71.06	0.00	33.77	2.58	3.52
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	2.11	6.64	3.02	0.91	5.74	52.22	0.30	22.64	1.51	3.62
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	4.07	3.78	2.61	1.16	8.13	47.35	1.16	19.17	1.16	2.61
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	1.60	4.00	1.60	0.27	7.99	56.22	0.53	17.85	2.40	1.87
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	2.63	1.75	2.63	0.00	6.57	66.54	1.31	24.08	2.19	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	1.37	4.10	2.28	1.82	10.02	55.56	0.91	21.41	3.64	4.55
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	4.48	0.00	0.75	2.24	9.70	53.70	3.73	11.93	2.98	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	2.88	6.48	0.72	0.36	5.40	70.95	1.44	28.45	2.88	3.24
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	2.30	7.77	2.30	0.58	8.34	67.33	0.58	35.10	1.15	2.30
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	1.65	7.31	1.65	0.47	4.24	68.59	0.00	30.40	2.83	2.36
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	3.49	4.75	2.85	0.32	3.49	83.98	1.27	40.88	3.80	4.44
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	2.15	5.54	3.08	0.62	6.77	66.74	0.31	40.29	3.69	2.77
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	4.81	4.49	2.24	0.96	8.66	75.02	0.00	28.21	3.53	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	3.06	8.80	1.91	1.15	3.82	58.52	0.38	20.27	2.29	2.68
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	3.15	5.12	1.18	0.39	4.34	53.99	0.79	20.49	0.39	2.36
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	2.27	8.32	1.51	0.76	6.05	56.73	1.51	18.91	3.78	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	2.41	3.21	0.80	0.00	8.83	44.97	0.80	8.83	4.82	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	0.70	3.50	2.10	0.70	9.79	55.25	2.10	7.69	3.50	4.20
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	6.01	4.01	3.01	4.01	14.02	77.13	2.00	17.03	6.01	2.00
Cardiac Myocyte, donor1	11525-119I4	5.48	7.31	5.48	1.83	0.00	1.83	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	11.36	7.41	16.30	2.47	2.96	0.49	0.99	0.00	0.00	0.99
Cardiac Myocyte, donor3	11686-122I3	25.57	4.21	15.26	3.37	1.47	2.10	2.84	0.32	0.74	0.32
Chondrocyte - de diff, donor1	11261-116G1	20.11	7.28	6.59	3.47	2.77	0.69	0.00	0.35	0.00	0.69
Chondrocyte - de diff, donor2	11338-117F6	14.93	6.75	9.24	2.84	1.78	0.00	0.00	0.36	0.71	0.36
Chondrocyte - de diff, donor3	11410-118E6	16.73	9.10	5.58	3.07	1.59	0.34	0.23	0.11	0.46	1.02
Chondrocyte - re diff, donor2	11339-117F7	7.16	12.53	3.58	5.37	5.37	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	8.90	7.68	2.02	3.64	2.83	0.00	0.00	0.40	0.40	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	22.49	14.00	4.82	7.69	9.75	2.41	1.95	0.92	0.46	0.80
Ciliary Epithelial Cells, donor2	11323-117D9	21.38	7.27	3.63	8.12	7.27	2.57	1.92	0.43	0.86	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	20.44	10.00	6.46	7.35	8.14	1.24	1.77	0.97	0.35	0.88
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	31.55	28.70	20.36	6.79	35.03	5.32	2.48	1.47	1.74	2.38
Corneal Epithelial Cells, donor1	11526-119I5	27.01	12.08	6.81	12.08	4.61	8.56	11.20	1.54	2.20	0.66
Corneal Epithelial Cells, donor2	11606-120I4	14.79	14.79	2.28	5.69	0.00	1.14	0.00	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	17.38	12.78	5.11	7.16	3.83	1.79	6.14	0.26	2.05	1.79
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	4.46	8.42	11.72	0.66	0.66	45.57	1.16	1.82	0.00	0.83
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	4.10	10.72	11.35	0.63	1.58	41.00	1.89	1.58	0.32	0.95
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	0.00	3.45	13.80	0.00	0.00	20.70	0.00	6.90	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	2.59	7.45	12.96	0.43	0.65	28.40	3.13	0.76	0.11	1.73
Dendritic Cells - plasmacytoid, donor1	11228-116C4	1.02	3.76	0.68	1.71	4.78	0.34	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	3.92	4.57	0.00	2.61	3.26	0.65	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	4.36	4.84	0.00	0.48	3.39	0.00	0.97	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	43.53	3.84	49.86	6.34	7.17	9.51	4.17	1.17	2.17	1.83
Endothelial Cells - Aortic, donor1	11263-116G3	33.45	2.35	25.23	4.69	5.28	4.69	2.93	0.59	3.52	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	31.96	3.11	30.54	7.07	14.71	2.55	1.70	1.70	2.26	1.70
Endothelial Cells - Aortic, donor3	11412-118E8	16.51	6.68	29.10	3.54	9.04	2.36	0.39	0.79	0.00	1.97
Endothelial Cells - Artery, donor1	11264-116G4	27.92	4.94	27.34	6.40	8.14	3.49	3.20	2.04	2.62	2.62
Endothelial Cells - Artery, donor2	11341-117F9	33.64	2.59	26.82	6.12	23.29	2.35	2.12	1.88	2.12	3.29
Endothelial Cells - Artery, donor3	11413-118E9	46.98	5.61	46.81	7.19	10.69	5.26	4.03	2.63	3.16	3.51
Endothelial Cells - Lymphatic, donor1	11236-116D3	23.27	4.43	33.47	4.43	7.76	6.65	3.99	1.55	1.55	2.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	23.73	5.48	34.08	6.39	8.82	14.91	5.48	2.74	0.30	2.43
Endothelial Cells - Lymphatic, donor3	11393-118C7	21.42	3.10	26.78	5.07	5.64	5.36	3.10	0.85	2.26	3.10
Endothelial Cells - Microvascular, donor1	11265-116G5	24.96	5.65	37.14	5.65	7.73	7.13	5.65	0.89	0.59	4.16
Endothelial Cells - Microvascular, donor2	11342-117G1	21.87	4.69	23.43	4.17	8.85	3.64	2.08	0.00	1.04	1.56
Endothelial Cells - Microvascular, donor3	11414-118F1	19.85	2.55	22.69	2.69	4.25	3.69	5.53	0.71	0.14	2.98
Endothelial Cells - Thoracic, donor1	11266-116G6	22.41	8.00	31.21	6.40	14.80	4.00	1.60	0.00	1.20	1.60
Endothelial Cells - Thoracic, donor2	11343-117G2	23.06	3.14	14.68	5.77	13.63	2.10	1.05	0.00	1.05	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	23.61	5.22	25.35	7.21	5.09	1.74	0.37	0.37	1.74	2.24
Endothelial Cells - Umbilical vein, donor2	11324-117E1	17.60	2.82	12.17	3.91	7.39	0.43	0.22	0.00	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	22.23	4.64	11.85	6.84	7.45	0.24	0.73	0.24	0.49	0.98
Endothelial Cells - Vein, donor1	11267-116G7	38.68	2.28	30.71	4.55	13.65	2.28	3.41	2.28	2.28	2.28
Endothelial Cells - Vein, donor2	11344-117G3	34.23	5.59	26.54	6.29	11.87	0.70	1.40	0.70	2.79	2.10
Endothelial Cells - Vein, donor3	11416-118F3	26.69	4.08	18.84	6.12	9.11	2.20	2.67	0.47	1.41	2.67
Eosinophils, donor1	12244-129H3	0.00	15.25	15.25	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1.65	11.55	0.00	0.00	11.55	1.65	0.00	1.65	0.00	1.65
Eosinophils, donor3	12246-129H5	3.57	10.70	0.00	7.13	3.57	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	10.51	7.09	3.66	5.38	2.20	1.95	2.44	0.49	0.00	0.98
Esophageal Epithelial Cells, donor2	11587-120G3	16.64	8.32	6.24	4.16	4.16	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	19.29	7.39	4.93	5.34	2.46	0.82	0.41	0.41	1.23	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	10.29	4.71	6.24	2.63	1.31	0.88	0.22	1.09	0.55	1.42
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	13.76	5.96	7.15	3.36	1.73	0.11	0.54	0.33	0.33	1.52
Fibroblast - Aortic Adventitial, donor1	11245-116E3	18.43	7.76	13.58	5.22	3.03	0.73	0.49	0.61	1.21	1.09
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	12.69	7.37	9.55	2.05	2.05	2.18	1.23	0.82	0.41	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	11.92	6.64	8.02	3.16	1.79	0.63	0.53	0.53	0.53	1.16
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	11.86	7.64	4.74	1.32	1.32	0.53	0.26	0.26	0.00	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	19.27	9.63	8.97	3.99	1.99	0.33	0.33	0.00	0.00	1.00
Fibroblast - Cardiac, donor1	11268-116G8	14.52	4.54	2.72	5.44	3.63	0.91	0.91	0.00	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	2.27	3.79	6.06	4.55	5.31	0.00	0.00	0.00	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	9.62	7.57	5.68	3.47	2.52	0.63	0.16	0.00	0.16	0.63
Fibroblast - Cardiac, donor4	11452-119A3	25.16	6.37	12.73	3.03	2.42	1.21	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	25.63	6.47	13.58	5.71	3.30	1.27	0.76	0.25	0.76	0.89
Fibroblast - Cardiac, donor6	11460-119B2	15.92	5.15	9.55	2.88	2.58	0.61	0.30	0.30	0.45	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	17.15	10.99	3.75	5.49	4.56	1.34	0.40	0.67	0.27	0.80
Fibroblast - Choroid Plexus, donor2	11572-120E6	6.47	6.04	1.73	1.29	3.02	0.00	0.43	0.00	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	14.65	10.25	2.93	4.39	4.39	0.00	1.46	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	44.51	9.69	11.07	14.99	4.15	1.38	0.92	0.46	1.15	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	17.81	9.33	4.58	3.05	2.04	0.00	0.00	0.00	0.51	0.34
Fibroblast - Dermal, donor1	11269-116G9	36.86	4.46	20.90	7.04	5.40	1.88	1.64	0.94	3.52	1.41
Fibroblast - Dermal, donor2	11346-117G5	54.71	8.02	31.60	9.91	10.38	2.36	0.94	1.42	7.55	1.89
Fibroblast - Dermal, donor3	11418-118F5	37.23	6.17	29.62	6.77	3.02	1.33	1.81	0.48	2.66	1.69
Fibroblast - Dermal, donor4	11450-119A1	26.23	7.57	5.99	8.82	4.07	0.57	0.23	0.11	0.45	0.90
Fibroblast - Dermal, donor5	11454-119A5	29.83	8.20	8.20	8.72	2.97	0.35	0.17	0.52	0.52	0.87
Fibroblast - Dermal, donor6	11458-119A9	30.70	7.15	7.63	12.51	4.55	0.65	0.16	0.49	0.49	0.32
Fibroblast - Gingival, donor1	11237-116D4	53.31	10.20	27.28	11.66	5.41	0.83	1.46	0.00	2.71	1.04
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	20.70	7.86	8.38	4.45	2.36	0.79	1.05	0.00	0.52	0.79
Fibroblast - Gingival, donor2	11318-117D4	30.05	8.43	7.12	10.54	4.35	0.13	0.79	0.00	0.92	2.11
Fibroblast - Gingival, donor3	11394-118C8	50.76	8.22	12.86	6.77	1.93	0.29	0.58	0.19	0.77	1.45
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	7.27	7.27	2.08	8.31	2.08	0.00	0.00	0.00	0.00	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	8.81	8.28	4.05	4.76	1.76	0.35	0.53	0.18	0.35	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	18.08	11.38	9.35	6.08	3.59	0.31	0.47	0.31	0.16	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	17.71	8.93	7.44	6.36	2.43	0.27	0.00	0.27	0.41	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	20.82	13.76	10.94	8.82	1.76	0.71	0.35	0.00	0.71	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	14.77	9.51	6.43	6.43	2.78	0.29	0.15	0.15	0.15	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	14.59	12.82	6.54	3.82	2.45	0.00	0.14	0.00	0.41	1.23
Fibroblast - Gingival, donor8 (control)	11926-125H9	9.65	7.68	4.28	3.51	4.72	0.11	0.33	0.11	0.33	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	8.51	9.68	2.35	3.52	2.05	0.00	0.15	0.15	0.15	0.59
Fibroblast - Lung, donor1	11270-116H1	38.06	6.80	16.31	10.87	9.52	1.36	0.00	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	38.80	4.48	10.45	8.95	2.98	0.00	1.49	0.00	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	40.94	8.86	14.35	13.72	9.92	0.42	0.84	0.00	1.06	1.48
Fibroblast - Lymphatic, donor1	11506-119G3	98.30	25.82	58.31	24.16	7.50	6.66	1.67	2.50	5.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	44.76	6.99	32.17	8.39	5.59	1.40	0.00	0.00	0.00	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	61.29	7.28	31.07	12.03	3.36	2.24	0.56	1.96	4.20	2.52
Fibroblast - Mammary, donor1	11540-120B1	100.27	15.02	73.48	28.42	11.77	4.87	4.87	1.22	6.50	4.06
Fibroblast - Mammary, donor2	11620-122A9	87.87	0.00	83.88	11.98	3.99	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	65.52	0.00	35.74	11.91	0.00	5.96	0.00	0.00	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	23.66	6.60	3.69	11.44	3.10	0.19	0.39	0.19	1.16	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	27.00	8.80	5.76	12.44	4.25	0.00	0.15	0.30	1.52	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	66.71	6.43	38.25	17.14	8.26	2.75	2.45	0.92	3.06	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	9.54	11.45	3.05	3.82	1.14	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	16.74	6.75	7.83	3.78	1.08	0.54	0.54	0.27	0.54	1.35
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	12.87	6.49	4.99	4.06	2.90	0.00	0.12	0.23	0.12	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	14.37	6.85	10.50	2.65	3.76	1.33	1.66	0.33	0.88	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	60.35	12.60	31.90	14.63	9.35	6.71	4.06	1.42	2.84	2.03
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	58.80	7.35	20.05	12.70	4.68	0.67	1.34	2.00	3.34	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	28.07	6.33	11.07	6.33	1.58	0.40	1.19	0.00	0.40	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	17.07	7.14	7.54	3.37	2.18	0.20	0.20	0.40	0.99	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	11.55	6.93	3.37	3.37	3.20	0.36	0.00	0.00	0.36	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	10.25	6.31	5.72	1.97	0.99	0.00	0.79	0.00	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	10.83	9.03	4.21	3.31	0.90	0.00	0.30	0.00	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	13.71	9.07	7.45	2.59	2.59	0.22	0.22	0.00	0.11	0.43
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	9.87	8.10	7.59	2.53	1.01	0.51	0.51	0.25	0.00	0.51
Fibroblast - skin normal, donor1	11553-120C5	15.10	8.04	10.50	3.61	1.31	0.49	0.82	0.00	0.33	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	12.03	11.83	7.02	2.41	4.01	0.00	0.80	0.20	0.20	0.40
Fibroblast - skin normal, donor2	11561-120D4	8.44	10.25	5.63	2.11	1.41	0.20	0.00	0.20	0.10	0.40
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	9.07	10.28	4.53	4.53	4.23	0.00	0.30	0.00	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	12.59	8.28	4.89	4.31	3.23	0.25	0.08	0.17	0.33	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	16.92	9.92	3.76	3.25	2.05	0.34	0.68	0.00	0.17	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	6.24	8.54	4.93	0.99	0.33	0.00	0.00	0.00	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	18.43	11.40	7.14	4.05	1.49	0.32	0.85	0.21	0.53	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	13.49	9.78	8.10	5.40	2.70	0.34	0.17	0.67	0.00	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	17.72	7.53	9.25	3.92	0.47	1.10	0.94	0.31	1.10	1.73
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	22.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	6.97	14.82	0.87	1.74	1.74	0.87	0.87	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	14.74	9.36	7.11	7.45	7.11	11.44	8.15	4.16	1.91	1.04
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	15.87	8.59	9.37	7.55	8.85	13.01	9.63	2.34	1.30	1.04
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	13.80	7.67	5.11	7.41	6.13	8.69	5.88	0.77	1.28	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	9.95	20.67	1.53	5.36	7.66	0.00	3.83	1.53	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	14.04	19.14	3.19	2.55	5.74	1.91	4.47	0.64	0.00	1.28
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	12.84	21.39	1.14	6.56	6.28	1.71	2.00	0.86	0.00	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	14.34	25.92	0.55	9.10	11.86	0.28	3.31	0.55	0.00	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	10.05	21.46	1.37	5.25	12.79	0.00	1.60	0.46	0.00	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	8.32	17.24	0.40	6.54	6.93	0.79	3.96	0.20	0.20	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	11.90	26.70	0.53	6.61	10.84	0.00	2.38	0.00	0.00	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	8.81	15.98	1.30	5.87	18.59	0.00	1.30	0.33	0.00	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	11.94	24.76	2.21	10.17	9.29	0.00	4.42	0.44	0.00	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	12.15	18.09	2.12	6.50	9.75	0.42	3.96	0.57	0.00	1.41
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	17.49	21.43	1.72	7.51	12.56	2.34	5.79	1.35	0.62	1.72
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	11.28	24.98	1.61	6.98	7.52	1.61	3.22	0.27	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	24.65	11.03	4.34	7.93	21.31	7.43	17.35	0.99	0.87	1.49
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	24.09	13.70	5.81	10.52	21.04	8.03	24.36	1.25	0.83	3.88
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	15.45	12.20	4.07	7.93	12.20	4.27	12.60	1.02	0.20	1.63
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	26.24	11.41	7.99	10.04	19.85	15.74	12.55	2.05	0.68	1.60
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	32.51	8.22	9.34	9.97	13.95	14.82	25.41	4.61	0.87	2.99
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	29.73	7.65	7.43	10.05	13.77	12.90	20.33	4.81	0.87	2.62
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	23.93	13.89	6.50	9.46	24.82	9.75	10.05	1.18	0.59	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	20.35	14.47	5.56	6.52	14.62	9.06	9.70	2.86	0.16	1.91
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	24.35	10.72	6.03	7.37	9.38	8.04	10.50	3.13	0.22	1.79
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	11.69	16.13	1.61	5.04	16.33	0.20	1.81	1.01	0.40	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	13.40	15.27	3.90	5.26	16.29	5.77	4.92	1.70	0.00	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	21.02	16.14	9.58	8.69	17.11	17.73	8.25	4.79	0.89	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	20.39	18.94	4.16	9.16	23.31	0.94	1.14	0.42	0.10	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	17.59	21.01	3.59	7.51	22.03	0.34	0.17	0.17	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	12.84	15.71	2.10	5.75	12.06	0.11	1.33	0.66	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	15.47	17.06	6.66	7.32	17.80	6.16	2.66	2.08	0.17	0.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	12.86	15.11	4.70	5.31	15.52	6.74	2.04	3.88	0.20	1.02
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	16.30	17.95	3.51	5.36	16.92	0.62	0.62	0.62	0.00	1.44
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	13.72	15.56	1.38	4.61	12.22	0.12	0.69	0.12	0.12	0.92
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	10.17	12.01	3.17	5.00	14.68	0.33	0.50	0.50	0.17	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	14.55	14.55	0.88	5.07	12.34	0.44	0.00	0.00	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	15.13	17.59	2.58	4.80	10.70	0.37	0.74	0.12	0.00	0.86
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	9.89	11.51	2.92	3.57	15.07	0.65	1.46	0.00	0.32	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	14.43	14.43	1.28	10.26	13.15	0.64	1.28	0.32	0.00	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	14.50	17.81	1.61	5.31	12.79	0.00	0.09	0.00	0.09	0.95
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	13.29	10.28	3.16	5.38	12.97	0.00	0.00	0.00	0.00	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	11.25	14.29	2.74	6.99	21.59	0.30	1.22	0.00	0.00	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	10.66	13.17	2.72	4.70	10.45	0.52	0.52	0.10	0.10	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	13.61	10.10	1.98	5.05	10.32	0.44	0.66	0.00	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	8.70	18.52	2.81	4.49	19.08	0.84	0.56	0.00	0.00	0.84
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	11.67	14.72	2.50	3.61	11.02	0.00	0.46	0.09	0.19	0.37
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	11.77	13.64	2.14	6.69	13.64	0.00	0.80	0.53	0.00	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	9.03	14.08	2.45	5.36	11.32	0.15	0.31	0.00	0.15	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	13.73	13.99	2.85	5.70	9.97	0.26	0.26	0.26	0.00	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	17.08	12.74	2.98	7.86	11.11	0.54	0.00	0.00	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	13.46	17.33	2.58	6.82	13.83	0.00	0.37	0.00	0.18	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	13.16	15.57	2.19	4.39	11.62	0.00	0.00	0.22	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	27.77	19.83	5.95	8.93	10.91	0.00	0.00	0.00	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	12.93	15.30	3.30	6.60	8.97	0.13	0.00	0.00	0.13	0.79
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	17.55	12.91	2.22	5.85	10.49	0.40	0.00	0.00	0.20	0.81
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	52.10	42.19	6.61	17.28	14.74	0.25	0.25	0.00	0.25	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	15.92	40.41	1.19	8.36	15.92	1.19	7.96	0.80	0.60	1.99
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	15.87	22.50	0.77	7.09	8.78	0.15	7.86	0.62	0.15	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	21.07	37.44	1.84	10.64	15.75	0.61	7.77	0.20	0.20	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	8.45	19.71	0.00	4.69	12.52	0.63	1.25	0.31	0.00	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	8.19	20.34	0.85	3.96	8.19	0.28	1.41	0.00	0.00	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	4.15	14.30	0.46	6.00	10.61	0.00	0.92	0.00	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	12.37	9.90	0.00	2.47	12.37	0.00	0.00	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	6.96	22.43	1.55	3.09	12.76	1.16	0.77	0.00	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	6.42	25.67	3.21	1.60	14.44	0.00	0.00	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	3.48	13.91	3.48	3.48	10.43	0.00	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	7.81	13.67	3.58	5.53	10.74	0.00	0.65	1.95	0.33	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	5.35	13.18	2.88	2.88	10.71	1.24	2.06	0.41	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	13.33	46.65	3.33	0.00	6.66	0.00	0.00	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	11.19	13.14	0.84	3.92	8.95	0.84	0.56	0.84	0.56	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	8.50	14.71	1.96	3.27	6.21	0.33	0.98	0.00	0.98	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	10.90	12.58	0.84	5.03	8.39	0.00	0.84	0.84	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	9.22	11.13	0.95	3.82	10.18	0.00	2.23	0.64	0.00	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	6.79	15.28	1.02	2.04	14.61	0.68	0.68	0.68	0.34	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	10.44	8.35	2.09	0.00	14.62	0.00	2.09	2.09	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	5.15	10.31	0.57	1.72	11.45	0.00	0.57	0.00	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	7.10	9.47	1.48	4.74	10.36	0.00	0.59	0.59	0.30	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	5.08	8.47	0.00	1.69	6.78	0.00	3.39	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	8.28	14.50	3.31	4.14	12.43	0.00	1.24	0.00	0.00	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	6.90	14.27	2.53	5.06	15.65	1.15	0.00	0.23	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	10.54	5.27	0.00	5.27	5.27	0.00	0.00	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	8.07	13.45	2.31	5.00	7.69	1.15	0.38	0.38	0.77	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	12.71	8.80	1.96	1.30	8.15	0.65	0.33	0.00	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	18.06	4.68	2.01	6.69	7.36	0.00	0.67	0.67	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	9.25	12.33	1.54	4.24	12.33	0.39	0.77	0.00	0.00	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	10.27	11.98	2.40	5.48	14.38	1.03	1.37	0.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	22.36	4.97	2.48	4.97	9.94	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	13.21	9.91	0.47	2.83	11.80	0.47	0.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	13.88	7.24	0.00	1.81	9.05	0.00	0.60	0.60	0.00	2.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	12.21	6.10	4.07	3.56	13.23	0.51	1.02	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	14.36	10.37	2.39	3.99	9.17	0.00	0.40	1.60	0.00	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	15.29	7.40	2.47	4.93	11.84	0.49	0.49	0.00	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	10.62	10.62	2.36	2.36	5.90	0.00	0.00	0.00	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	12.25	8.75	1.17	3.50	12.25	0.00	0.58	0.00	0.58	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	10.97	7.90	0.88	5.27	11.41	0.88	0.00	0.44	0.00	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	7.63	6.78	1.70	2.54	12.72	0.00	0.85	0.00	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	6.57	10.15	1.19	2.39	6.57	0.60	0.00	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	5.82	8.25	2.43	4.37	9.70	0.00	0.00	0.00	0.49	2.43
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	12.55	10.27	1.14	5.71	6.85	1.14	0.00	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	12.47	7.90	4.16	4.57	5.41	0.83	0.83	0.00	1.25	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	65.22	19.12	35.98	22.49	7.87	1.12	0.00	1.12	3.37	3.37
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	22.52	7.61	13.64	1.59	1.90	1.27	0.32	0.00	0.63	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	21.30	4.60	19.63	1.25	0.42	0.42	0.00	0.00	0.84	1.67
Hep-2 cells mock treated, biol_rep1	11898-125E8	3.25	11.26	0.46	1.97	1.74	0.70	1.16	0.00	0.12	0.81
Hep-2 cells mock treated, biol_rep2	11899-125E9	3.38	10.97	1.35	1.86	1.86	0.34	1.18	0.68	0.51	0.34
Hep-2 cells mock treated, biol_rep3	11900-125F1	2.73	10.24	0.91	3.87	2.50	0.46	0.46	0.46	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	3.83	9.29	1.09	1.97	2.30	0.66	1.31	1.09	0.44	0.22
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	6.66	9.46	0.43	3.01	1.07	0.43	2.15	0.43	0.21	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	2.58	7.32	0.43	1.08	2.58	0.43	0.43	0.43	0.00	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	2.62	6.73	1.87	2.24	1.99	0.12	1.87	0.25	0.00	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	2.23	6.00	1.03	1.54	2.74	0.69	0.51	1.03	0.34	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	4.16	8.33	0.64	0.64	0.96	0.64	0.64	0.32	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	19.59	3.36	20.71	3.92	6.16	0.56	0.56	0.00	0.00	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	31.59	6.06	15.15	9.09	7.36	2.16	1.30	0.43	1.30	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	37.01	5.29	34.37	2.64	5.29	0.00	0.00	0.00	0.00	7.93
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	15.87	15.87	7.76	6.70	4.94	0.35	2.47	0.00	1.41	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	20.34	10.90	4.36	3.63	2.91	0.73	0.00	0.00	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	7.52	8.04	3.85	3.50	3.50	0.35	0.17	0.17	0.17	0.35
Hepatocyte, donor1	11523-119I2	15.74	18.16	6.05	2.42	1.21	1.21	0.00	1.21	0.00	3.63
Hepatocyte, donor2	11603-120I1	49.56	10.77	23.70	21.55	5.39	10.77	4.31	2.15	2.15	3.23
Hepatocyte, donor3	11684-122I1	23.31	12.27	5.52	6.14	0.61	0.61	0.61	0.61	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	41.12	47.65	4.57	14.36	30.68	1.31	5.22	1.96	0.65	2.61
Intestinal epithelial cells (polarized), donor1	11246-116E4	101.55	15.73	34.26	24.99	34.43	53.31	22.20	22.02	13.11	7.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	28.54	8.23	6.04	7.13	6.45	2.88	2.61	0.82	0.41	1.10
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	25.47	19.10	0.00	15.92	9.55	38.21	15.92	3.18	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	53.40	13.35	6.68	13.35	13.35	73.43	6.68	13.35	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	0.00	0.00	27.08	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	15.23	5.54	2.77	13.84	8.31	41.53	11.08	4.15	0.00	5.54
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	2.50	2.50	5.01	15.02	52.56	10.01	5.01	0.00	5.01
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	23.74	11.87	0.00	0.00	23.74
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	20.50	5.13	10.25	17.94	12.81	20.50	15.38	5.13	0.00	15.38
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	18.28	9.14	4.57	4.57	13.71	32.00	9.14	9.14	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	21.12	3.25	3.25	4.87	16.24	37.36	6.50	4.87	1.62	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	20.01	3.33	5.00	11.67	21.67	23.34	6.67	5.00	0.00	5.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	21.78	0.00	0.00	0.00	21.78	61.72	7.26	0.00	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	21.18	17.21	3.97	10.59	9.26	46.32	6.62	7.94	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	21.06	5.54	6.65	5.54	14.41	26.61	6.65	3.33	1.11	4.43
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	5.24	0.00	15.71	15.71	41.91	10.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	15.75	6.30	3.15	6.30	13.86	34.64	5.67	5.67	1.26	4.41
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	12.37	9.28	4.64	9.28	13.92	23.20	7.73	6.19	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00	0.00	0.00	29.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	23.26	18.74	3.23	9.04	9.04	26.49	9.04	7.11	0.00	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	28.98	19.32	8.05	6.44	12.88	25.76	3.22	6.44	0.00	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	11.95	0.00	0.00	11.95	47.79	23.90	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	27.71	13.85	7.33	13.04	16.30	28.52	7.33	5.70	1.63	3.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	17.21	6.30	6.30	13.01	19.31	35.68	8.82	4.62	0.42	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	14.37	14.37	0.00	0.00	14.37	0.00	14.37	0.00	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	26.52	8.84	3.21	7.23	19.29	32.95	8.04	6.43	0.00	4.02
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	18.47	8.31	6.46	5.54	15.70	19.39	7.39	2.77	2.77	2.77
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	15.08	0.00	0.00	15.08	0.00	0.00	0.00	0.00	15.08
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	15.58	8.50	5.66	7.08	9.44	6.61	8.02	2.36	0.00	3.30
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	9.98	7.26	5.44	9.98	13.60	18.14	9.98	1.81	0.91	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	14.74	0.00	0.00	14.74	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	20.45	16.14	5.38	9.69	10.76	13.99	10.76	2.15	0.00	4.30
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	15.25	8.89	7.62	10.16	22.87	19.06	5.08	5.08	0.00	3.81
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	16.43	0.00	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	18.49	8.29	10.84	10.20	14.03	17.22	5.74	5.10	0.00	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	16.40	7.29	5.47	1.82	18.23	14.58	5.47	0.00	0.00	3.65
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	15.80	0.00	15.80	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	20.71	9.28	6.43	10.00	19.99	15.71	8.57	5.00	1.43	4.28
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	36.50	16.59	16.59	19.91	16.59	23.23	3.32	3.32	0.00	6.64
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	83.39	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	19.14	9.26	5.25	8.33	16.05	15.12	3.70	4.32	0.00	1.23
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	21.07	10.54	5.27	10.54	14.05	14.05	5.27	5.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	28.29	9.43	3.14	22.00	3.14	18.86	3.14	9.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	20.17	9.04	2.78	13.21	19.47	18.78	6.26	6.26	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	48.69	17.70	6.64	15.49	30.98	68.61	19.92	8.85	0.00	6.64
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	16.21	3.24	0.00	16.21	38.90	32.42	3.24	6.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	34.01	8.72	3.49	6.10	18.31	57.55	8.72	11.34	0.00	6.10
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	33.75	13.50	4.50	15.75	11.25	67.49	20.25	18.00	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	34.85	10.45	10.45	20.91	10.45	55.75	10.45	24.39	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	37.34	11.73	9.60	13.87	13.87	59.74	9.60	12.80	0.00	6.40
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	15.24	15.24	4.16	9.70	16.63	36.02	11.08	8.31	0.00	2.77
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	34.20	2.85	11.40	8.55	22.80	25.65	2.85	0.00	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.93	9.20	4.60	10.12	19.33	45.10	11.05	6.44	0.92	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	45.38	9.08	6.05	9.08	9.08	60.51	3.03	9.08	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	55.88	0.00	12.42	24.83	6.21	86.92	6.21	24.83	0.00	12.42
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	29.61	11.63	1.06	14.80	10.57	51.81	6.34	13.75	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	14.85	10.61	9.06	8.49	6.36	14.04	7.92	5.71	2.20	1.63
Keratinocyte - epidermal, donor2	11349-117G8	23.43	5.27	9.96	7.61	7.03	4.10	11.71	2.34	1.17	0.59
Keratinocyte - epidermal, donor3	11421-118F8	18.74	8.90	4.45	8.52	3.98	4.64	10.70	1.04	1.14	1.80
Keratinocyte - oral, donor1	11251-116E9	23.38	8.29	6.02	11.24	4.20	7.38	11.24	0.79	1.36	1.02
Keratocytes, donor1	11527-119I6	62.58	4.13	16.85	13.75	4.47	2.75	1.72	0.00	1.38	1.03
Keratocytes, donor2	11607-120I5	48.04	10.55	12.89	7.03	8.20	2.34	1.17	1.17	2.34	4.69
Keratocytes, donor3	11688-122I5	34.18	1.78	10.47	3.95	2.96	0.59	0.40	0.40	0.59	0.79
Krukenberg tumor cell line:HSKTC	10687-109F3	351.67	15.39	43.96	52.75	39.56	13.19	24.18	21.98	15.39	13.19
Lens Epithelial Cells, donor1	11529-119I8	22.65	4.31	8.63	7.55	11.87	1.08	1.08	0.00	0.00	3.24
Lens Epithelial Cells, donor2	11609-120I7	18.34	10.73	2.54	6.11	8.53	0.81	1.27	0.12	0.46	0.23
Lens Epithelial Cells, donor3	11690-122I7	15.34	6.76	8.27	5.05	6.96	1.72	2.42	0.81	0.20	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	23.36	4.86	31.54	6.52	6.52	12.57	7.11	0.71	0.95	2.96
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	15.91	4.74	16.19	3.91	4.74	6.98	2.23	0.00	0.56	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	12.28	5.98	20.94	4.09	3.94	4.56	2.99	0.94	0.31	2.05
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	14.52	5.38	22.58	4.30	6.45	5.91	1.61	0.00	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	18.91	3.78	24.58	3.15	8.82	6.93	5.04	1.26	0.32	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	14.34	5.07	19.19	3.34	4.64	5.61	2.16	0.54	0.65	2.26
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	17.24	1.64	16.83	3.28	4.92	9.44	3.28	0.41	0.82	2.87
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	18.20	4.30	21.49	5.06	4.30	9.86	4.05	0.76	0.25	2.28
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	16.33	4.93	22.24	4.79	6.05	5.21	4.50	0.56	0.28	1.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	13.84	1.58	21.75	5.54	6.33	11.47	3.96	1.58	1.98	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	14.15	3.68	17.45	4.27	5.04	8.53	3.88	0.39	0.58	1.55
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	18.51	5.18	23.88	5.18	5.00	6.30	1.30	1.11	0.56	1.30
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	13.59	3.48	21.95	2.79	5.57	7.67	4.53	0.35	0.70	2.79
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	15.74	5.72	22.66	4.29	5.49	9.78	4.53	0.24	0.00	1.67
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	15.38	5.49	23.07	3.71	5.08	7.42	2.06	0.41	0.55	1.51
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	16.01	3.70	21.25	3.70	5.54	11.70	4.93	1.54	1.23	2.16
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	13.09	3.43	21.20	5.92	5.61	9.98	3.74	1.25	0.31	2.18
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	20.13	5.67	33.67	4.76	5.86	8.42	3.48	1.10	0.91	1.83
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	13.82	2.63	15.80	3.95	3.95	11.52	3.29	0.99	0.33	2.63
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	12.89	5.27	24.60	4.69	6.74	12.59	2.64	0.88	1.17	2.34
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	18.67	4.73	26.64	6.22	8.21	8.46	3.24	0.50	0.75	1.49
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	15.52	2.91	16.97	3.88	4.85	8.24	2.42	1.45	1.45	1.94
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	17.77	2.15	24.24	2.96	4.58	9.69	2.15	1.35	0.54	1.35
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	15.59	5.30	20.74	4.54	5.15	5.90	5.00	0.15	1.06	1.67
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	10.37	1.04	12.96	6.22	4.67	12.96	4.15	1.56	1.04	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	15.49	3.98	22.82	3.14	4.40	13.19	3.77	0.84	0.42	1.88
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	14.29	4.81	23.01	4.66	5.26	5.86	2.71	0.60	1.50	2.41
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	15.82	3.44	18.57	2.75	8.25	10.32	4.13	1.38	0.00	2.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	15.62	2.63	19.94	4.70	4.14	11.10	2.82	0.38	0.75	1.51
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	14.74	3.29	20.57	4.56	5.51	7.00	2.54	0.64	0.42	2.01
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	15.02	3.39	23.26	4.36	7.75	5.33	2.42	2.91	2.91	1.45
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	15.22	3.64	16.87	4.30	3.64	10.59	3.97	1.32	0.99	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	12.76	4.21	19.82	2.97	4.71	4.34	3.22	0.25	0.12	1.61
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	15.18	2.22	12.22	4.44	2.96	6.29	2.96	1.48	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	11.37	3.21	17.30	5.68	4.20	11.86	3.71	0.99	0.74	1.24
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	12.51	4.67	18.29	3.71	4.40	6.05	3.16	0.41	0.41	1.37
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	17.37	2.89	16.08	3.54	4.18	7.40	3.54	0.64	2.25	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	13.09	3.96	19.78	3.35	4.87	7.91	2.74	0.30	0.91	1.83
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	10.92	4.34	17.36	3.78	4.34	6.44	4.48	0.42	0.28	1.26
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	17.07	4.98	22.40	1.78	3.20	8.89	3.56	0.36	0.71	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	17.94	2.91	22.30	2.42	6.79	8.73	1.94	0.48	0.48	2.42
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	14.78	4.05	21.47	5.14	5.60	8.56	5.91	0.16	0.62	2.02
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	17.55	2.51	27.22	2.51	3.94	6.45	3.58	1.43	0.36	3.58
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	19.93	3.92	21.23	3.59	4.57	11.43	6.21	0.98	0.65	0.98
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	14.13	5.18	24.25	4.00	5.89	6.36	4.00	0.94	0.94	1.41
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	25.37	5.57	32.55	6.31	6.81	10.40	7.18	2.10	1.61	2.48
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	15.62	4.10	21.77	5.12	6.40	11.78	3.59	1.54	0.00	2.82
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	17.60	5.07	22.38	4.77	8.95	5.97	3.58	0.30	0.90	1.79
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	2.27	54.38	2.27	4.53	13.60	0.00	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	14.58	32.22	3.07	6.14	11.51	1.53	8.44	0.77	0.00	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	12.62	22.27	3.71	5.94	6.68	0.00	2.23	0.74	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	12.69	37.24	5.92	3.81	14.39	1.27	2.54	2.96	0.00	2.12
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	8.44	31.65	2.11	2.81	11.25	3.52	2.11	1.41	0.70	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	11.21	37.36	4.67	2.80	7.47	1.87	3.74	1.87	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.31	35.04	7.21	7.21	9.27	0.52	1.03	1.03	0.52	3.09
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	10.71	33.30	3.57	2.38	9.52	1.19	1.19	1.19	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	10.40	32.57	3.62	7.24	12.44	2.04	3.62	0.68	0.23	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	8.43	27.63	2.04	2.62	7.27	1.45	2.91	1.45	0.00	2.33
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	10.35	36.01	1.80	2.25	8.55	1.80	2.70	0.45	0.00	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	15.31	44.44	4.06	5.55	9.35	2.03	3.93	1.08	0.68	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	10.78	38.00	3.08	6.68	10.27	1.54	1.54	1.54	0.00	2.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	9.17	27.88	3.53	4.23	7.76	0.35	3.88	0.71	0.71	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	5.33	26.65	1.33	0.67	4.00	0.67	1.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	14.77	43.30	7.13	5.60	13.24	1.02	3.06	1.02	0.00	4.08
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	8.54	26.68	1.60	4.80	8.27	1.07	2.67	1.33	0.27	1.87
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	8.31	38.36	3.40	5.29	8.12	1.70	3.59	0.76	0.19	2.08
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	10.43	35.59	3.68	2.45	12.27	2.45	1.23	2.45	0.61	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	12.23	39.14	4.08	4.89	9.79	1.63	9.79	0.00	0.00	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	8.75	37.48	2.29	3.12	6.66	0.83	2.92	0.83	0.42	3.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	8.13	30.27	3.36	3.08	7.85	1.12	2.24	1.68	0.00	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	13.39	43.27	0.00	4.12	15.46	2.06	4.12	2.06	1.03	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	7.26	32.22	2.32	3.19	8.13	0.87	4.06	1.45	0.00	2.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	8.07	30.79	2.69	2.09	6.88	0.30	1.49	0.60	0.90	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	6.09	28.77	2.77	3.87	7.75	1.11	1.66	1.66	0.55	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	12.73	44.54	4.24	4.24	13.79	2.83	3.89	1.77	0.35	3.53
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	7.38	31.72	2.21	2.58	9.96	1.11	2.58	1.11	0.00	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	12.66	42.60	0.00	4.61	10.36	1.15	2.30	0.00	0.00	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	8.06	34.92	3.07	3.84	10.75	0.77	4.61	1.54	0.38	2.30
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	8.49	40.20	2.83	2.83	10.76	1.70	2.26	3.40	0.00	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	5.74	28.72	1.64	0.82	5.74	1.64	2.46	0.82	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	13.56	43.83	1.81	2.71	16.27	1.36	5.42	0.45	0.45	2.71
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	2.87	38.78	1.44	2.87	12.21	1.44	0.72	0.00	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	5.23	31.37	0.75	5.98	11.20	0.75	3.73	1.49	0.00	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	9.66	32.70	1.86	4.46	9.66	0.37	4.46	1.49	0.74	3.34
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	3.88	34.46	1.29	1.72	9.05	0.86	2.15	0.00	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	11.99	39.39	0.00	5.99	9.42	3.43	3.43	4.28	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	9.66	36.98	2.33	5.00	11.99	1.00	4.00	1.00	0.33	2.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	6.03	38.01	1.81	4.22	14.48	1.81	1.81	0.60	0.00	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	10.66	30.57	3.55	4.98	8.53	1.42	2.84	0.00	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	8.94	35.06	3.09	5.84	11.69	1.03	3.44	1.03	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	7.51	32.74	2.68	2.68	15.57	1.61	2.15	0.54	0.00	4.29
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	10.77	38.38	1.35	1.35	8.75	0.67	5.39	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	12.96	31.86	0.74	4.07	11.85	1.48	6.30	1.11	0.00	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	8.14	34.89	1.16	3.49	16.28	3.49	5.81	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	7.40	35.96	1.06	3.17	11.64	0.00	3.17	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	13.20	34.41	1.60	4.80	12.40	0.00	5.20	1.60	0.00	2.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	15.26	41.43	4.36	7.27	12.36	1.45	3.63	1.45	0.73	1.45
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	16.86	54.42	6.13	6.13	16.10	0.77	4.60	2.30	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	14.31	53.77	2.47	5.92	10.85	0.99	4.93	1.48	0.49	2.96
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	9.41	35.76	5.65	3.76	14.11	3.76	2.82	0.00	0.00	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	19.11	43.75	3.02	4.02	12.07	3.02	5.53	4.02	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	16.22	41.01	2.70	6.76	12.62	1.35	1.35	1.35	0.45	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	6.88	39.59	0.00	0.00	10.33	8.61	0.00	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	13.36	46.76	4.45	6.68	11.13	2.67	4.90	0.89	0.45	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	14.86	40.28	7.43	7.04	12.90	0.78	4.69	1.56	0.00	4.69
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	11.22	42.22	5.94	4.62	11.22	1.32	4.62	1.32	0.66	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	19.20	48.26	3.11	7.26	11.94	0.52	6.75	2.59	0.00	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	15.75	50.32	6.13	7.88	7.88	1.75	2.63	3.94	0.44	5.69
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	7.27	36.34	3.35	4.47	11.18	0.56	3.35	1.68	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	11.48	44.16	3.97	7.95	12.81	1.32	2.65	0.44	0.44	2.21
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	15.81	42.04	4.24	4.24	14.66	1.16	3.47	1.54	0.00	3.86
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	11.65	39.50	3.04	5.06	11.65	1.01	1.01	0.51	0.51	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	14.90	37.01	3.36	4.81	12.50	1.44	6.25	3.84	0.00	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	9.54	30.21	5.57	4.37	13.91	1.59	4.37	1.19	0.40	2.78
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	7.90	34.63	2.43	3.65	11.54	1.82	1.22	0.61	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	4.15	31.13	4.15	4.15	8.99	0.69	2.08	0.00	0.00	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	13.30	41.80	2.28	7.60	16.34	2.28	2.66	2.66	0.00	1.90
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	5.16	40.80	0.52	4.13	10.33	1.55	2.58	0.52	0.00	4.13
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	6.65	40.51	2.42	1.21	6.05	1.21	3.63	1.21	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	7.29	34.86	2.22	4.44	11.09	1.58	2.85	2.54	0.00	2.54
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	8.53	44.78	3.20	6.40	18.13	1.07	1.07	1.07	0.00	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	6.32	34.48	2.87	2.87	19.54	0.57	2.87	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	8.23	37.02	4.11	3.09	12.86	2.06	3.60	1.03	0.00	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	8.49	33.25	1.41	7.07	12.73	0.71	2.83	1.41	0.00	2.12
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	5.67	43.13	3.97	3.97	19.86	1.70	5.11	2.27	0.00	2.27
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	9.57	37.44	1.25	3.33	14.98	1.25	4.16	0.42	0.00	3.33
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	3.13	38.37	0.78	3.13	13.31	1.57	3.13	1.57	0.00	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	5.43	39.67	2.51	3.76	14.20	0.84	1.67	1.25	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	7.43	38.10	0.93	4.65	15.33	0.93	4.65	0.46	0.46	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	6.69	40.14	2.68	2.68	12.04	0.00	1.34	1.34	0.00	2.68
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	6.95	29.94	0.53	2.67	12.83	1.07	5.35	1.07	0.00	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	3.23	38.39	0.00	3.23	12.93	3.23	3.64	0.40	0.40	2.02
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	8.26	39.46	1.84	5.51	19.27	0.00	4.59	1.84	0.00	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	4.45	36.45	2.67	2.67	13.34	1.78	1.78	0.89	0.00	2.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	9.69	42.17	2.28	5.13	15.39	1.14	3.99	0.57	0.00	2.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	3.83	44.48	0.77	5.37	15.34	2.30	1.53	0.77	0.00	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	6.02	35.57	4.92	6.02	9.30	0.55	3.28	0.55	0.00	2.19
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12.47	37.86	1.78	5.79	16.04	0.89	3.12	0.45	0.00	1.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	8.32	39.25	2.86	7.54	17.16	0.26	3.64	0.78	0.26	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	9.28	49.07	1.99	5.97	19.23	1.33	1.99	1.33	0.00	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	10.39	41.57	2.08	10.39	18.71	0.00	0.00	4.16	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	15.95	12.54	33.96	1.82	1.60	1.37	0.23	0.46	0.00	1.82
Macrophage - monocyte derived, donor2	11313-117C8	5.32	10.09	19.45	0.92	1.84	10.83	3.67	0.55	0.37	0.37
Macrophage - monocyte derived, donor3	11389-118C3	13.37	11.54	21.10	1.44	1.05	3.93	1.97	0.13	0.39	0.92
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	9.56	6.37	3.19	3.72	5.31	6.37	1.59	2.12	2.12	1.59
Mallassez-derived cells, donor2	11929-125I3	11.25	6.02	7.61	5.70	3.96	6.65	5.86	2.22	0.79	0.79
Mallassez-derived cells, donor3	11930-125I4	14.87	7.37	8.06	4.45	6.53	12.51	10.84	3.06	1.67	1.39
Mammary Epithelial Cell, donor1	11273-116H4	56.50	12.65	32.18	11.56	9.57	20.13	18.53	3.49	7.67	2.19
Mammary Epithelial Cell, donor2	11350-117G9	38.80	7.24	15.06	10.13	7.24	11.29	12.16	2.61	3.19	2.90
Mammary Epithelial Cell, donor3	11422-118F9	65.10	10.23	16.96	12.47	6.49	7.73	16.21	1.25	2.00	1.50
Mast cell - stimulated, donor1	11487-119E2	2.71	5.42	10.85	0.00	0.00	153.89	7.46	8.81	0.68	4.75
Mast cell, donor1	11563-120D6	28.22	13.19	14.38	9.62	6.38	6.70	3.89	3.24	0.22	1.19
Mast cell, donor2	11565-120D8	19.32	9.81	10.40	8.92	11.29	1.19	1.19	0.30	0.30	1.19
Mast cell, donor3	11566-120D9	32.42	16.43	14.63	10.81	12.83	2.03	0.90	0.68	0.23	0.45
Mast cell, donor4	11567-120E1	26.42	12.23	11.70	9.93	3.90	0.89	0.89	1.06	0.53	0.89
Mast cell, expanded and stimulated, donor5	11940-126A5	28.83	11.42	16.63	10.76	9.32	35.49	6.65	8.43	0.22	1.00
Mast cell, expanded and stimulated, donor8	11942-126A7	2.92	11.09	8.17	0.58	2.92	31.52	2.92	4.67	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	34.42	11.01	18.47	13.65	9.98	6.42	0.57	4.02	0.11	1.72
Mast cell, expanded, donor8	11941-126A6	16.40	13.05	6.36	8.70	4.02	1.17	0.84	1.51	0.00	1.17
Melanocyte - dark, donor1	11502-119F8	11.54	6.57	16.02	5.17	3.58	0.20	1.19	0.30	0.30	1.49
Melanocyte - dark, donor2	11582-120F7	13.84	4.85	12.11	3.81	3.11	0.00	0.35	0.00	0.00	0.69
Melanocyte - dark, donor3	11663-122F7	11.52	16.15	3.26	5.22	2.54	0.29	0.07	0.07	0.07	0.07
Melanocyte - light, donor1	11274-116H5	11.99	10.34	5.64	5.41	9.17	0.24	0.00	0.24	0.47	1.18
Melanocyte - light, donor2	11351-117H1	31.39	10.24	10.92	10.24	12.28	0.68	0.00	1.36	0.00	2.05
Melanocyte - light, donor3	11423-118G1	18.21	10.41	4.34	4.34	1.73	0.00	0.00	0.00	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	8.54	9.79	2.19	1.77	2.19	0.00	0.00	0.00	0.10	0.21
Melanocyte, donor2 (MC+2)	12739-135I3	23.13	6.45	6.99	5.11	5.11	0.27	0.81	0.00	0.81	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	14.73	7.77	4.82	5.62	5.09	0.00	0.00	0.00	0.54	0.54
Meningeal Cells, donor1	11493-119E8	52.60	12.16	22.33	12.53	6.08	1.86	0.37	0.62	1.36	0.99
Meningeal Cells, donor2	11573-120E7	30.81	11.00	13.20	7.48	5.28	0.88	0.00	0.44	0.00	0.44
Meningeal Cells, donor3	11654-122E7	22.90	7.91	17.28	9.05	5.79	1.30	0.82	0.49	1.63	0.73
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	33.65	10.27	8.55	11.12	4.56	0.57	1.14	0.29	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	9.16	4.73	3.72	3.02	2.92	0.20	0.20	0.00	0.00	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	86.73	14.46	40.74	9.20	3.94	0.00	1.31	1.31	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	78.49	10.47	22.24	15.70	11.77	3.92	0.00	0.00	3.92	3.92
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	20.81	6.46	7.18	10.76	5.02	0.00	2.15	1.44	0.72	2.87
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	20.12	10.38	12.28	6.35	2.54	2.33	0.85	0.85	1.06	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	32.67	8.54	16.59	7.04	1.01	2.01	0.00	1.01	4.02	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	27.03	9.23	10.99	9.45	7.91	0.44	1.10	0.22	2.86	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	24.84	12.42	15.34	4.38	7.31	0.73	1.46	0.00	0.73	1.46
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	28.85	10.84	12.89	7.98	4.50	0.61	0.82	0.20	2.05	0.82
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	20.64	7.20	4.99	3.60	1.25	0.14	0.14	0.28	0.69	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	14.50	11.90	4.83	4.09	4.83	0.00	0.00	0.00	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	13.03	7.89	4.61	3.03	2.37	0.13	0.13	0.00	0.39	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	7.42	7.12	1.48	0.89	4.45	0.00	0.00	0.00	0.30	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	14.01	11.68	0.00	2.34	9.34	0.00	0.00	2.34	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	12.81	6.40	6.40	3.20	5.76	0.00	0.00	0.00	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	29.42	10.63	8.51	8.86	1.77	0.35	1.06	0.35	2.13	1.06
Mesenchymal stem cells - hepatic, donor0	11218-116B3	14.07	7.82	5.32	3.13	1.56	0.00	0.00	0.31	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	8.71	9.43	2.18	5.08	4.35	0.00	0.00	0.00	0.00	1.45
Mesothelial Cells, donor1	11247-116E5	14.05	10.61	15.11	7.69	3.45	6.10	3.18	1.86	1.59	1.33
Mesothelial Cells, donor2	12156-128G5	9.51	10.01	4.00	7.01	2.50	5.51	2.00	1.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	11.06	8.89	4.84	4.62	4.48	4.34	2.53	1.01	0.51	0.87
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	9.45	9.45	9.45	1.35	10.80	2.70	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	19.70	10.10	30.78	2.46	4.68	9.36	5.66	0.49	0.49	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	11.48	11.48	28.56	1.47	3.24	12.07	5.89	0.29	0.29	1.47
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	10.37	13.83	3.46	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	14.88	7.75	24.80	2.79	3.41	6.20	3.41	0.00	1.86	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	10.37	5.39	24.06	1.04	2.28	14.31	5.19	0.83	0.21	1.04
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	0.00	4.63	0.00	2.32	2.32	4.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	18.27	10.01	35.04	2.50	4.25	11.76	7.01	0.50	0.50	2.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	6.05	5.12	20.95	0.93	5.12	9.31	2.33	0.00	0.00	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	14.02	7.72	28.65	2.44	2.85	9.96	4.67	0.41	0.61	2.85
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	9.11	8.71	20.19	1.98	3.17	15.84	2.77	0.00	0.40	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	8.55	0.00	8.55	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	8.85	4.42	13.27	0.88	2.65	12.39	0.88	0.00	0.00	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	6.84	9.88	34.95	4.18	4.18	27.36	5.32	0.76	0.76	1.90
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	15.79	5.26	9.21	0.00	14.47	3.95	0.00	0.00	1.32	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	14.22	5.73	23.13	1.91	2.97	21.86	3.82	1.49	1.70	1.27
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	5.52	2.76	3.68	1.84	2.76	9.21	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	10.73	3.58	15.50	1.19	5.07	26.23	5.07	1.79	1.19	1.49
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	13.41	1.68	8.38	0.00	5.03	5.03	0.00	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	10.54	4.01	30.11	2.01	3.01	46.67	6.02	3.51	2.51	2.76
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	8.56	4.28	17.83	0.95	4.75	35.41	5.94	2.85	0.48	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	5.53	1.66	9.95	2.76	6.63	35.38	2.76	2.76	1.11	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	11.05	1.61	16.35	0.92	2.07	77.82	9.21	5.53	1.15	2.99
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	8.83	4.00	19.77	0.63	1.89	65.63	6.73	5.05	1.89	1.47
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	12.84	2.85	18.55	1.63	2.85	80.72	8.76	6.93	1.83	3.06
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	10.08	4.72	23.38	1.29	2.36	67.37	9.65	3.00	1.29	1.50
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	7.34	2.45	11.34	0.67	2.67	44.46	4.22	5.33	0.44	1.78
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	0.00	0.00	0.00	0.00	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	8.98	1.31	11.61	1.75	3.07	86.07	6.79	7.23	0.88	1.97
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	8.11	4.06	5.58	3.55	2.03	30.42	2.53	2.03	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	1.66	3.31	0.00	1.66	19.88	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	8.15	1.90	12.77	1.09	2.72	66.32	6.79	5.16	1.09	1.36
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	6.47	4.41	12.65	1.18	3.23	66.46	3.23	9.70	1.18	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	0.00	5.45	1.09	5.45	8.72	2.18	2.18	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	8.17	3.84	9.61	1.44	0.96	76.89	4.32	7.69	0.48	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	4.00	2.40	12.01	0.40	1.60	66.84	4.80	4.80	1.20	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	4.11	1.37	1.37	1.37	0.00	6.86	0.00	1.37	2.74	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	7.01	2.50	9.51	1.00	3.00	63.57	1.50	9.51	1.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	53.89	0.00	0.00	53.89	26.95	26.95	0.00	53.89
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	6.12	0.00	2.04	0.00	2.04	6.12	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	4.38	3.50	6.57	0.88	2.19	24.96	2.19	3.07	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	8.83	1.10	1.10	3.31	4.41	7.73	0.00	0.00	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	3.84	1.92	1.28	1.28	1.28	5.76	0.00	1.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	3.97	4.21	4.46	0.50	1.98	30.74	3.72	5.70	0.50	2.48
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	4.18	5.57	4.87	0.70	2.78	13.92	0.70	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	13.26	2.21	2.21	2.21	2.21	4.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	8.21	4.79	10.94	2.74	1.37	19.83	4.44	1.37	0.00	1.71
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	5.25	3.50	6.56	0.00	0.00	4.38	0.88	0.88	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	13.85	2.49	4.62	0.36	4.26	3.20	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	5.05	5.89	11.50	2.24	3.93	17.39	2.81	1.68	0.28	1.12
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	5.40	4.16	9.14	1.66	0.42	8.73	2.08	1.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	7.58	3.50	3.50	1.75	2.91	0.58	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	5.73	5.43	9.35	0.60	1.51	9.65	0.30	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	5.84	4.17	12.94	1.67	3.76	14.61	2.09	0.00	0.42	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	14.44	0.00	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	5.54	7.39	5.54	0.00	2.77	4.62	0.92	0.92	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	12.52	5.69	13.09	1.71	3.41	10.24	2.85	0.00	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	9.53	4.01	5.67	1.52	2.76	1.93	1.24	0.00	0.14	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	6.48	5.18	10.37	1.81	3.11	8.03	0.78	0.78	0.26	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	9.87	2.14	8.58	1.72	4.29	9.44	3.00	0.00	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	10.16	3.81	7.62	2.54	2.54	1.27	1.27	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	4.27	4.80	4.00	1.07	3.47	2.94	0.27	0.80	0.00	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	16.16	7.48	24.55	3.29	1.50	12.87	2.39	0.30	0.60	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	10.45	3.81	9.04	1.55	2.83	0.85	0.71	0.14	0.14	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	7.96	10.83	11.47	1.91	3.82	6.05	1.59	0.00	0.00	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	11.06	6.41	12.16	3.32	1.55	15.26	2.43	0.44	0.66	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	9.86	3.03	6.07	3.79	3.41	0.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	7.95	7.39	9.94	1.99	1.99	3.69	1.14	0.00	0.00	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	10.32	9.09	15.73	3.69	2.70	19.91	3.44	0.49	0.00	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	11.73	5.21	9.78	2.61	1.30	1.30	0.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	10.29	7.35	11.17	3.23	3.53	2.94	2.65	0.59	0.00	2.06
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	9.51	10.67	19.32	0.86	1.15	8.94	2.31	0.86	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	8.66	9.89	18.55	4.53	2.06	4.95	0.82	0.82	0.00	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	8.34	8.34	16.68	2.98	2.38	2.38	1.49	0.00	0.30	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	7.53	7.53	0.00	0.00	0.00	0.00	0.00	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	30.30	8.91	28.52	5.35	3.56	1.78	0.00	0.00	0.00	3.56
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	32.20	6.24	38.11	3.61	1.64	1.97	0.33	0.66	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	16.83	18.94	12.62	3.16	0.00	4.21	4.21	0.00	0.00	3.16
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	10.48	7.91	30.84	1.58	2.17	1.38	0.20	0.20	0.00	1.19
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	27.01	3.73	42.84	0.00	4.66	6.52	2.79	0.00	0.00	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	28.16	7.89	63.09	2.25	2.25	3.00	0.38	0.75	1.13	1.50
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	11.45	10.92	22.64	1.60	1.60	6.39	3.73	0.00	0.80	1.60
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	10.97	9.84	14.25	2.15	1.47	0.57	0.57	0.23	0.34	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	18.42	5.16	28.73	1.47	0.74	1.47	0.74	0.00	0.74	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	27.48	6.23	27.48	1.83	1.10	1.47	0.37	0.73	1.10	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	10.89	7.78	15.56	3.11	4.67	4.67	0.00	4.67	0.00	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	0.53	0.00	5.34	0.53	0.00	1.07	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	27.05	0.00	19.32	0.00	0.00	3.86	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	19.19	11.11	23.23	4.04	5.05	0.00	0.00	0.00	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	3.79	2.95	6.75	0.00	0.84	1.69	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	0.00	1.36	5.45	0.00	1.36	0.00	0.00	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.27	0.00	1.27	0.00	2.54	2.54	0.64	0.00	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.81	0.81	0.00	0.00	2.43	0.81	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	0.00	3.02	1.51	1.51	1.51	0.00	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	11.42	11.42	17.13	0.00	11.42	0.00	0.00	0.00	11.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	0.00	3.26	16.31	0.00	9.79	26.10	6.52	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	0.00	23.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	12.55	25.10	0.00	12.55	12.55	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	15.30	10.13	7.54	4.96	5.39	0.43	1.29	0.00	1.29	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	16.20	11.50	7.84	3.66	4.70	0.00	0.00	0.00	0.52	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	73.42	5.34	17.35	14.02	4.67	1.33	0.00	0.00	2.67	3.34
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	82.64	4.17	15.86	9.18	4.59	0.42	0.83	0.42	0.83	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	36.70	9.13	9.51	3.99	2.85	1.33	1.71	0.00	3.23	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	70.22	6.38	23.94	11.17	20.75	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	70.03	4.76	19.04	8.84	4.08	0.00	0.00	1.36	0.68	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	23.89	5.51	11.03	5.51	1.84	3.68	5.51	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	56.92	3.35	8.79	8.37	5.44	0.42	0.00	0.42	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	72.99	8.14	19.99	8.60	4.65	1.63	0.93	0.70	1.63	0.93
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	51.88	6.22	8.11	9.46	3.51	1.08	0.27	0.27	0.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	27.12	6.52	5.47	3.99	5.89	0.42	0.00	0.00	0.63	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	89.08	11.13	11.13	0.00	0.00	11.13	0.00	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	28.79	6.45	6.45	7.45	5.96	0.50	0.50	0.50	0.50	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	23.01	8.93	6.77	2.17	1.35	1.35	0.27	0.54	1.35	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	63.24	4.76	17.00	5.67	3.17	0.91	0.45	0.45	1.36	1.36
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	42.62	4.41	6.21	3.43	3.43	0.49	0.33	0.16	0.16	0.49
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	18.04	4.56	5.47	5.47	2.55	0.00	0.00	0.00	0.55	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	38.19	4.24	11.14	5.83	2.65	0.53	0.00	0.00	0.53	2.65
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	28.81	2.40	5.40	4.20	1.20	0.60	0.00	0.00	0.60	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	17.07	7.55	10.17	0.98	0.33	1.97	0.98	0.00	0.66	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	58.38	4.72	10.41	4.88	1.79	0.33	0.49	0.00	0.65	0.65
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	23.11	5.64	5.29	3.35	5.12	0.53	0.00	0.18	0.18	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	34.46	2.11	8.44	4.22	1.41	0.70	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	35.40	3.22	5.06	5.52	1.84	0.46	0.00	0.46	0.46	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	41.45	4.18	11.57	5.78	1.61	0.32	0.00	1.29	0.96	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	27.59	7.24	11.04	1.03	0.69	2.41	2.07	1.38	0.69	2.41
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	17.70	15.17	7.59	5.06	0.00	2.53	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	22.28	3.34	5.35	2.01	3.56	0.89	0.00	0.00	0.67	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	33.45	5.50	6.35	2.96	1.27	0.00	0.00	0.42	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	28.01	3.80	4.51	2.37	2.37	0.24	0.00	0.24	0.71	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	48.08	6.44	7.30	4.29	1.72	0.00	0.43	0.00	0.43	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	0.00	9.03	9.03	0.00	0.00	9.03	9.03	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	58.65	2.00	5.33	7.33	4.33	0.00	0.33	0.00	0.33	1.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	15.78	3.16	3.61	5.41	5.86	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	18.25	4.76	3.97	2.78	3.17	0.40	0.00	0.00	0.79	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	36.22	1.86	7.43	1.86	0.93	0.93	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	35.95	4.92	7.19	3.03	1.89	0.00	0.00	0.00	0.76	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	36.83	5.54	5.54	3.26	0.65	0.33	0.65	0.33	0.65	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	66.24	2.18	3.92	5.67	2.18	0.00	0.00	0.44	0.44	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	21.71	2.26	4.07	2.71	13.12	0.45	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	27.34	4.41	6.17	1.76	1.76	0.00	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	24.60	5.32	3.32	3.99	5.32	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	49.11	5.46	6.45	3.47	2.48	0.99	0.00	0.00	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	33.31	3.06	3.06	4.98	2.30	0.00	0.38	0.38	0.38	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	44.16	5.75	7.56	3.63	2.12	0.91	0.00	0.30	0.30	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	11.27	7.29	5.75	3.09	4.42	1.33	0.00	0.00	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	21.68	3.39	8.13	4.07	3.39	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	0.00	5.11	5.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	49.38	4.88	8.54	7.32	0.61	0.00	0.00	1.83	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	31.79	3.46	5.67	3.46	1.89	0.00	0.31	0.31	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	67.79	4.24	8.47	4.24	2.42	0.00	0.30	0.30	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	22.15	4.75	2.37	0.79	2.37	0.79	0.00	0.00	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	13.60	9.07	4.53	2.27	4.53	3.40	1.13	1.13	1.13	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	10.12	10.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	32.67	6.21	32.67	5.59	4.47	5.84	3.60	2.86	5.47	2.36
Myoblast, donor2	11322-117D8	33.37	7.86	23.01	7.48	4.99	1.92	2.11	0.77	1.92	1.73
Myoblast, donor3	11398-118D3	40.86	9.25	28.08	12.28	8.41	5.55	3.03	0.67	4.88	1.35
NK T cell leukemia cell line:KHYG-1	10777-110G3	15.47	9.19	0.58	8.46	3.79	13.86	1.31	0.15	0.00	0.15
Natural Killer Cells, donor1	11230-116C6	10.46	8.00	1.85	4.31	11.38	7.07	0.92	0.00	0.31	1.23
Natural Killer Cells, donor2	11311-117C6	6.94	3.02	0.90	4.22	11.76	4.82	0.60	0.00	0.30	0.60
Natural Killer Cells, donor3	11387-118C1	10.68	5.71	2.58	3.68	11.41	1.66	0.92	0.00	0.00	0.74
Neural stem cells, donor1	11275-116H6	5.44	22.87	2.18	3.63	10.16	0.00	0.36	0.36	0.00	0.73
Neural stem cells, donor2	11352-117H2	11.55	65.47	1.93	1.93	13.48	0.00	0.00	0.00	1.93	0.00
Neurons, donor1	11494-119E9	15.93	27.31	1.14	5.69	10.24	0.00	0.00	1.14	1.14	2.28
Neurons, donor2	11574-120E8	17.17	24.66	1.54	9.91	17.39	0.44	1.32	0.22	0.22	0.00
Neurons, donor3	11655-122E8	21.38	27.13	0.82	9.04	8.22	0.82	0.00	0.82	2.47	1.64
Neutrophils, donor1	11233-116C9	5.57	12.99	1.86	6.50	1.86	0.00	0.00	0.93	0.00	0.93
Neutrophils, donor2	11314-117C9	2.90	8.70	8.70	0.00	0.00	0.00	0.00	0.00	2.90	2.90
Neutrophils, donor3	11390-118C4	15.27	17.71	4.28	9.77	6.11	0.00	0.00	0.00	0.00	1.22
Nucleus Pulposus Cell, donor1	11252-116F1	17.22	7.60	3.68	1.90	2.14	0.00	0.12	0.00	0.24	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	14.98	7.81	3.91	5.54	1.95	0.00	0.00	0.00	0.33	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	41.51	4.41	13.24	6.42	2.41	1.00	1.40	0.40	0.40	0.60
Olfactory epithelial cells, donor1	11933-125I7	14.04	7.71	5.64	5.64	3.85	0.83	0.69	0.14	0.41	0.69
Olfactory epithelial cells, donor2	11934-125I8	17.37	10.28	9.26	5.93	2.03	1.01	0.58	0.87	0.29	1.45
Olfactory epithelial cells, donor3	11935-125I9	19.07	8.17	6.24	6.02	1.70	0.23	0.68	0.57	0.23	0.79
Olfactory epithelial cells, donor4	11936-126A1	23.38	9.45	4.68	7.40	2.73	0.49	0.29	0.29	0.29	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	30.69	3.61	12.64	8.43	12.64	28.89	21.67	9.63	0.60	3.01
Osteoblast - differentiated, donor1	11276-116H7	30.84	6.59	12.55	2.77	2.34	0.85	0.85	0.43	1.28	0.64
Osteoblast - differentiated, donor2	11353-117H3	18.29	5.72	13.72	2.29	5.72	3.43	1.14	0.00	0.00	2.29
Osteoblast - differentiated, donor3	11425-118G3	32.90	5.59	11.79	1.86	1.86	0.62	0.00	0.00	0.62	0.62
Osteoblast, donor1	11277-116H8	24.82	15.83	8.99	7.82	9.19	0.39	0.39	0.20	0.39	1.17
Osteoblast, donor2	11354-117H4	7.73	8.43	3.51	2.81	2.11	0.00	0.00	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	14.22	12.26	6.22	4.44	4.98	0.53	0.71	0.36	0.71	0.53
Pancreatic stromal cells, donor1	11249-116E7	24.18	8.93	10.78	4.89	3.20	0.76	0.42	0.34	0.51	1.10
Pericytes, donor1	11491-119E6	24.26	23.81	6.12	5.79	4.23	0.78	0.45	0.22	0.00	0.45
Pericytes, donor2	11571-120E5	23.99	17.43	3.62	4.30	6.34	0.45	1.13	1.13	0.23	0.68
Pericytes, donor3	11652-122E5	33.77	9.36	16.48	6.51	3.46	2.64	1.02	0.81	1.22	1.63
Perineurial Cells, donor1	11499-119F5	60.47	6.67	19.33	15.37	7.80	4.52	3.39	0.57	3.28	2.03
Perineurial Cells, donor2	11579-120F4	20.33	8.10	13.99	4.51	2.94	1.47	1.01	0.18	0.37	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	6.69	12.11	1.91	4.46	4.78	2.87	0.00	0.00	0.00	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	6.86	9.55	1.71	3.67	2.94	0.98	0.49	0.73	0.00	1.22
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	7.38	5.31	1.42	2.72	2.59	1.16	0.00	0.13	0.26	0.26
Placental Epithelial Cells, donor1	11278-116H9	24.39	11.72	7.17	8.85	6.46	2.63	2.63	6.94	0.96	0.24
Placental Epithelial Cells, donor2	11355-117H5	37.70	11.09	8.87	15.52	11.09	3.33	5.54	1.11	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	28.66	6.48	9.62	8.25	5.10	0.59	1.57	0.98	0.39	0.98
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	9.49	7.28	7.91	4.75	1.58	0.32	0.00	0.63	0.63	0.63
Preadipocyte - breast, donor1	11467-119B9	15.76	7.50	13.13	5.63	3.56	0.75	0.19	0.38	0.38	1.13
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	8.35	9.01	6.27	1.31	2.35	0.26	0.26	0.52	0.39	0.13
Preadipocyte - breast, donor2	11328-117E5	9.46	8.56	5.63	3.83	0.90	0.00	0.23	0.45	0.23	1.13
Preadipocyte - omental, donor1	11468-119C1	13.85	13.00	13.11	3.73	4.37	1.39	0.43	0.64	0.64	0.32
Preadipocyte - omental, donor2	11329-117E6	12.66	7.86	10.04	1.75	1.75	0.00	0.87	0.44	0.87	0.44
Preadipocyte - omental, donor3	11403-118D8	21.06	7.45	10.17	4.58	3.01	0.57	0.86	0.72	1.58	0.86
Preadipocyte - perirenal, donor1	11469-119C2	47.24	8.86	26.58	4.92	2.95	2.95	1.97	2.95	0.98	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	19.96	15.97	17.81	6.14	6.45	1.84	0.31	0.92	0.31	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	13.81	11.16	7.97	6.55	6.55	0.18	0.53	0.00	0.18	1.06
Preadipocyte - subcutaneous, donor3	11428-118G6	17.37	10.05	10.90	3.92	4.77	1.19	0.34	0.51	0.17	0.85
Preadipocyte - visceral, donor1	11280-116I2	24.87	11.18	11.55	8.10	7.73	0.84	0.28	0.09	1.58	0.47
Preadipocyte - visceral, donor2	11357-117H7	14.27	13.35	13.35	3.22	6.90	0.00	0.00	0.92	2.30	1.84
Preadipocyte - visceral, donor3	11429-118G7	22.36	8.99	16.82	5.22	3.45	0.73	1.15	0.52	0.94	1.15
Prostate Epithelial Cells (polarized), donor1	11253-116F2	65.32	13.43	28.51	18.25	36.36	57.32	21.72	14.78	12.52	5.58
Prostate Epithelial Cells, donor2	11331-117E8	12.19	5.69	7.31	5.01	3.93	7.18	4.20	5.01	1.08	1.49
Prostate Epithelial Cells, donor3	11404-118D9	43.05	8.14	9.49	9.86	11.51	3.43	2.69	1.47	7.23	1.71
Prostate Stromal Cells, donor1	11254-116F3	14.12	10.14	8.09	3.76	3.42	0.68	0.23	0.23	0.34	0.57
Prostate Stromal Cells, donor2	11332-117E9	21.16	8.43	6.99	7.17	2.69	0.72	0.18	0.36	0.54	1.43
Prostate Stromal Cells, donor3	11405-118E1	16.58	6.88	6.99	4.28	1.98	0.42	0.52	0.10	0.21	1.36
Renal Cortical Epithelial Cells, donor1	11516-119H4	49.64	9.12	17.15	14.23	12.41	39.78	32.85	21.17	1.82	4.01
Renal Cortical Epithelial Cells, donor2	11596-120H3	30.50	4.64	14.56	8.32	10.54	57.67	24.19	15.53	2.29	3.81
Renal Epithelial Cells, donor1	11517-119H5	59.35	15.22	21.81	23.84	27.90	19.78	11.16	6.59	3.55	4.06
Renal Epithelial Cells, donor2	11597-120H4	34.85	15.65	19.92	12.80	21.34	19.92	14.94	11.38	2.13	2.13
Renal Epithelial Cells, donor3	11678-122H4	29.75	6.78	17.26	11.33	16.09	42.35	18.53	11.65	1.80	2.75
Renal Glomerular Endothelial Cells, donor1	11514-119H2	18.38	7.49	21.11	10.89	6.81	1.36	1.36	0.00	0.68	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	25.87	5.93	20.35	6.87	8.89	2.70	1.35	0.67	0.27	1.35
Renal Glomerular Endothelial Cells, donor3	11675-122H1	15.32	7.55	8.21	5.55	8.88	1.55	1.55	0.89	1.11	2.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	21.96	11.98	17.97	6.65	4.66	0.67	0.67	1.33	1.33	2.00
Renal Mesangial Cells, donor1	11518-119H6	38.52	14.53	13.87	11.44	13.87	9.02	9.24	1.54	1.32	0.88
Renal Mesangial Cells, donor2	11598-120H5	29.47	12.54	5.02	13.17	12.54	3.76	3.76	1.25	0.63	2.51
Renal Mesangial Cells, donor3	11679-122H5	42.17	13.59	11.65	13.59	8.88	14.43	15.26	4.16	1.66	5.27
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	47.78	10.74	22.28	15.03	16.37	37.04	25.77	10.47	2.15	7.25
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	28.25	7.59	20.66	8.43	12.23	33.31	24.88	11.39	2.53	5.06
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	40.31	9.84	15.04	12.54	13.88	17.74	16.78	5.59	1.74	5.01
Retinal Pigment Epithelial Cells, donor0	11215-116A9	60.15	6.74	8.04	17.37	13.74	2.85	4.93	1.81	2.07	3.11
Retinal Pigment Epithelial Cells, donor1	11528-119I7	35.81	11.65	11.37	12.22	15.35	2.84	1.42	1.99	1.14	1.42
Retinal Pigment Epithelial Cells, donor2	11608-120I6	28.82	11.32	5.15	9.26	18.52	1.03	2.06	1.03	1.03	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	19.57	5.77	12.80	7.03	10.04	2.26	1.76	2.51	1.51	1.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	30.60	13.63	14.17	10.29	5.88	2.81	1.87	2.00	1.47	1.60
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	8.04	7.15	0.89	4.47	4.47	0.00	0.89	0.00	0.00	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	6.05	17.06	1.10	1.65	4.40	0.00	0.00	0.00	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	5.80	13.92	0.58	1.74	5.80	0.00	0.00	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	6.37	16.77	1.04	2.99	4.42	0.00	0.00	0.13	0.26	0.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	7.05	15.99	0.79	4.57	5.86	0.10	0.10	0.40	0.10	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	6.80	17.07	1.12	6.47	6.47	0.00	0.00	0.00	0.33	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	8.68	19.47	1.86	4.59	4.34	0.25	0.12	0.12	0.12	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	7.34	15.03	1.28	6.29	6.76	0.12	0.12	0.12	0.23	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	5.55	13.17	0.69	5.32	6.47	0.00	0.00	0.00	0.69	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	9.31	14.51	0.96	4.52	5.61	0.14	0.00	0.00	0.27	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	9.68	13.31	1.66	5.75	6.05	0.15	0.00	0.15	0.15	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	7.35	12.01	0.90	5.38	6.99	0.18	0.18	0.00	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	7.75	15.49	1.15	3.01	7.03	0.00	0.29	0.00	0.29	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	9.87	13.09	1.07	5.37	6.22	0.00	0.43	0.11	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	8.63	17.04	2.43	5.31	6.42	0.00	0.22	0.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	4.40	14.15	0.57	3.25	3.25	0.00	0.00	0.00	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	7.64	13.79	0.93	6.80	6.80	0.00	0.28	0.09	0.19	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	7.14	18.98	1.88	5.07	7.70	0.19	0.19	0.00	0.75	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	7.43	11.81	1.06	4.25	5.57	0.13	0.13	0.00	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	7.98	14.60	1.46	5.74	6.62	0.10	0.10	0.19	0.29	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	8.98	18.90	3.06	6.49	6.30	0.00	0.57	0.19	0.38	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	7.16	15.38	1.07	4.16	5.66	0.32	0.00	0.21	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	7.29	12.61	2.24	5.89	7.01	0.00	0.00	0.56	0.00	1.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	6.15	17.09	2.22	6.15	6.32	0.34	0.00	0.00	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	6.02	15.86	1.09	2.92	4.38	0.00	0.00	0.18	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	11.53	19.38	2.21	5.40	7.60	0.12	0.12	0.00	0.74	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	9.40	17.86	0.67	6.98	7.79	0.13	0.13	0.27	0.13	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	6.84	20.29	1.65	2.83	5.19	0.00	0.24	0.24	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	9.33	19.64	2.18	6.55	7.94	0.00	0.20	0.40	0.20	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	11.46	20.34	3.04	5.61	7.48	0.00	0.00	0.00	0.23	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	7.46	18.04	4.35	3.94	4.98	0.00	0.00	0.00	0.00	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	5.97	18.80	1.33	5.09	8.63	0.44	0.00	0.22	0.22	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	7.94	18.80	1.25	4.18	6.27	0.21	0.00	0.21	0.84	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	10.09	20.86	1.62	3.90	5.92	0.13	0.40	0.27	0.00	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	8.86	14.99	1.70	4.94	8.86	0.00	0.17	0.00	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	8.48	17.35	1.74	3.08	7.52	0.19	0.39	0.19	0.39	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	8.77	18.23	2.75	3.09	6.36	0.17	0.17	0.17	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	8.64	15.64	1.78	6.45	8.78	0.00	0.00	0.41	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	9.19	18.06	2.79	6.40	8.37	0.00	0.16	0.00	0.33	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	7.84	15.51	0.34	3.58	4.77	0.00	0.51	0.00	0.17	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	7.40	18.94	0.59	6.51	7.84	0.00	0.00	0.15	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	10.40	11.46	0.27	5.86	7.20	0.00	0.27	0.00	0.53	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	4.29	15.76	0.55	2.90	5.39	0.00	0.00	0.00	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	9.05	11.91	0.48	7.86	7.38	0.00	0.00	0.00	0.00	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	11.29	13.10	1.21	4.43	12.90	0.00	0.00	0.00	0.20	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	10.08	15.26	2.26	3.86	5.84	0.00	0.09	0.00	0.38	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	10.13	11.53	1.75	4.89	6.99	0.00	0.00	0.00	0.35	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	9.07	13.00	2.42	3.02	6.65	0.00	0.00	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	12.61	11.26	2.94	5.75	5.14	0.24	0.00	0.00	0.00	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	13.39	20.38	4.08	6.70	7.86	0.44	0.58	0.15	0.87	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	7.91	18.86	1.83	6.08	9.13	0.00	0.61	0.61	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	15.07	11.15	2.11	5.43	4.52	0.30	0.00	0.00	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	12.67	13.12	1.13	6.56	8.14	0.23	0.23	0.23	0.23	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	15.88	16.77	0.90	5.99	9.29	0.60	0.30	0.00	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	11.57	15.59	2.48	4.72	5.43	0.00	0.24	0.12	0.59	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	14.30	14.73	2.35	5.55	8.75	0.00	0.00	0.43	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	12.62	12.62	1.80	6.01	9.62	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	42.50	11.10	9.03	11.66	4.33	1.13	0.56	0.38	0.94	1.32
Schwann Cells, donor2	11578-120F3	23.82	3.40	0.00	10.21	10.21	0.00	0.00	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	19.72	7.01	7.01	6.35	6.57	0.88	0.22	0.22	0.88	0.66
Sebocyte, donor1	11220-116B5	29.58	16.98	7.67	13.69	7.12	3.29	6.03	3.83	2.74	0.55
Sebocyte, donor2	11301-117B5	9.65	11.03	2.76	4.60	2.30	2.30	1.84	2.76	0.00	0.46
Sebocyte, donor3	11378-118B1	60.80	11.13	17.52	12.57	4.33	2.47	1.86	0.21	3.09	2.06
Sertoli Cells, donor1	11255-116F4	39.76	13.25	13.25	9.94	3.31	1.66	1.66	3.31	1.66	1.66
Sertoli Cells, donor2	11333-117F1	11.30	11.30	5.65	0.00	2.82	0.00	0.00	0.00	0.00	5.65
Skeletal Muscle Cells, donor1	11281-116I3	23.75	10.82	6.25	6.86	6.69	0.79	0.62	0.26	0.62	0.53
Skeletal Muscle Cells, donor2	11358-117H8	28.19	7.23	8.67	3.61	3.61	0.72	0.72	1.45	0.00	1.45
Skeletal Muscle Cells, donor3	11430-118G8	31.77	10.03	10.87	10.87	15.05	1.67	0.84	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	27.96	7.70	12.10	8.33	6.13	0.47	0.63	0.63	0.31	1.41
Skeletal Muscle Cells, donor5	11455-119A6	22.30	7.28	10.26	6.99	4.91	1.49	0.59	0.59	1.04	1.19
Skeletal Muscle Cells, donor6	11459-119B1	41.86	8.16	11.08	13.08	4.92	2.00	2.15	0.46	1.69	2.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	26.59	8.82	11.59	4.91	2.77	1.13	0.38	0.13	0.50	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	25.26	7.71	8.56	4.57	3.14	0.14	0.29	0.14	0.71	1.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	26.59	7.64	10.22	9.72	7.34	0.40	0.89	0.30	0.79	1.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	13.06	10.78	3.37	3.79	6.32	0.25	0.42	0.17	0.59	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	44.15	10.13	10.13	6.51	3.62	0.00	0.00	0.00	2.17	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	14.72	11.42	4.82	3.44	4.27	0.14	0.69	0.28	0.14	1.10
Skin - palm, donor1	10286-104F7	53.72	26.86	18.80	0.00	2.69	2.69	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	11.53	4.47	5.77	4.76	4.04	3.17	2.45	1.01	0.29	1.59
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	13.90	13.09	11.45	1.64	8.18	10.63	6.54	4.09	3.27	3.27
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	8.96	5.84	4.41	3.89	2.60	1.82	1.17	0.52	0.78	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	18.21	7.65	8.20	5.28	4.31	5.70	6.12	0.42	1.81	1.67
Small Airway Epithelial Cells, donor2	11334-117F2	13.64	7.74	4.50	2.81	4.64	2.39	5.20	0.28	1.55	1.41
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	16.49	11.00	8.03	8.25	10.78	8.46	9.52	1.27	1.06	2.11
Small Airway Epithelial Cells, donor3	11406-118E2	13.64	5.40	4.27	5.17	4.05	1.72	1.65	0.60	0.97	0.82
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	21.60	11.11	7.71	2.47	2.16	0.62	1.85	0.93	0.31	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	9.12	6.89	5.78	1.11	1.33	0.22	0.22	0.00	0.89	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	41.74	13.52	9.99	8.82	5.88	0.00	1.76	0.00	1.18	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	29.17	12.38	14.36	9.50	3.76	1.55	1.77	0.44	1.77	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	27.17	12.99	14.18	7.88	4.33	1.58	0.79	1.18	2.36	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	33.99	13.91	12.36	13.13	7.73	3.09	0.00	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	4.00	9.01	2.00	0.00	2.00	0.00	0.00	0.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	15.97	7.45	5.99	5.86	3.73	0.13	0.27	0.67	0.80	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	20.17	8.64	13.74	3.99	3.10	1.99	0.44	0.22	0.89	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	14.60	7.94	6.66	3.97	4.61	0.90	0.64	0.26	0.64	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	19.54	6.84	9.12	3.26	2.60	0.65	0.65	0.33	0.33	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	23.33	10.34	7.68	5.61	5.02	2.36	0.89	0.59	1.18	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	10.11	5.55	4.27	2.14	1.71	0.43	0.43	0.14	0.28	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	62.14	9.27	34.49	14.15	8.13	5.53	3.25	0.33	4.88	2.28
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	22.53	5.48	9.13	3.35	2.13	0.61	0.30	0.61	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	26.77	9.60	7.32	5.81	5.56	0.25	0.51	0.25	0.76	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	42.84	0.00	18.36	6.12	0.00	0.00	0.00	12.24	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	12.87	9.06	5.72	5.25	4.77	0.00	0.48	0.00	0.48	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	17.55	4.72	7.82	5.31	3.39	1.33	0.15	0.29	1.62	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	12.27	4.09	5.38	4.52	2.15	0.00	0.00	0.43	0.00	1.51
Smooth Muscle Cells - Colonic, donor3	11396-118D1	19.21	7.24	8.08	6.09	4.72	0.31	0.52	0.73	1.15	0.84
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	34.65	13.15	18.56	8.82	5.88	2.63	1.08	1.39	1.08	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	30.18	8.62	19.40	5.39	6.47	2.16	4.31	0.00	2.16	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	11.36	10.46	4.18	4.78	5.08	0.30	0.30	0.00	0.00	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	30.04	8.88	9.90	12.29	10.58	0.34	0.68	0.00	1.02	1.37
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	11.86	8.09	1.41	4.00	2.36	0.16	0.08	0.00	0.00	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	28.38	8.86	16.51	12.38	8.45	1.81	0.91	1.31	5.54	1.01
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	24.12	7.28	15.02	6.60	7.96	2.50	1.82	1.14	1.37	2.28
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	13.28	6.64	9.06	7.85	3.02	0.60	1.21	1.21	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	26.76	7.15	10.86	7.42	3.44	0.26	0.53	0.00	0.79	1.32
Smooth Muscle Cells - Prostate, donor1	11257-116F6	21.17	9.72	7.32	5.19	3.20	1.73	0.27	0.27	0.40	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	7.89	8.14	4.63	3.51	1.88	0.38	0.00	0.13	0.25	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	26.89	7.61	41.85	3.30	2.79	2.79	0.51	0.25	0.76	1.27
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	38.45	11.91	20.66	10.40	7.54	3.02	1.06	0.15	1.36	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	24.76	11.25	8.25	4.50	3.00	0.00	0.75	0.75	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	100.79	63.32	54.27	40.06	10.34	3.88	0.00	1.29	1.29	5.17
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	15.35	13.49	2.79	8.84	5.58	0.00	0.00	0.47	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	22.21	9.09	17.17	11.61	6.06	3.03	1.51	0.50	1.01	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	26.33	6.89	23.19	5.95	6.89	2.51	2.51	2.19	1.88	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	32.45	9.14	21.24	6.78	5.90	2.65	3.24	0.29	0.88	2.36
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	29.57	8.58	13.41	10.33	8.00	0.42	0.92	0.17	1.42	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	26.16	6.54	3.27	3.27	1.87	0.47	0.00	0.00	0.00	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	23.75	7.63	12.23	6.33	5.18	1.30	1.44	2.88	1.01	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	24.22	8.67	8.92	6.88	4.33	2.04	0.51	1.02	1.78	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	17.11	8.09	6.58	7.15	2.44	0.75	0.56	0.19	0.38	1.13
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	20.26	7.55	6.29	7.13	1.68	0.00	0.28	0.14	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	10.22	9.22	2.60	4.61	1.93	0.17	0.08	0.08	0.17	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	57.62	7.14	10.00	16.67	6.19	1.90	0.95	0.48	1.43	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	25.93	6.61	13.70	6.85	4.65	0.49	0.00	1.71	1.47	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	6.85	7.73	7.29	3.09	1.77	0.88	0.88	0.22	0.22	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	28.38	11.70	7.90	6.14	4.68	1.17	1.17	0.00	0.59	1.17
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	7.19	6.22	2.53	1.55	1.36	0.19	0.00	0.00	0.39	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	21.42	7.40	16.40	3.17	1.59	1.59	0.53	1.06	1.06	2.91
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	18.23	4.84	19.34	1.49	1.12	1.49	0.00	1.12	0.37	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	20.84	5.39	19.40	2.52	3.59	2.16	0.00	1.44	1.44	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	27.25	5.96	27.54	5.68	4.26	6.53	1.99	1.99	3.12	1.99
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	5.51	6.30	12.60	5.91	3.94	0.39	0.39	0.00	0.39	1.58
Smooth muscle cells - airway, control, donor1	11966-126D4	16.00	7.36	10.16	2.54	3.30	1.02	0.76	0.00	0.00	2.03
Smooth muscle cells - airway, control, donor2	11967-126D5	17.97	4.39	3.99	1.20	3.99	0.00	0.00	0.40	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	16.72	9.61	11.29	1.67	0.84	0.84	0.42	1.25	1.25	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	20.17	9.63	6.88	1.38	2.29	0.00	0.92	0.46	0.00	1.38
Synoviocyte, donor1	11291-117A4	15.99	8.58	21.04	3.03	1.68	9.43	2.69	1.35	4.04	1.01
Synoviocyte, donor2	11368-117I9	14.08	4.53	4.86	3.35	0.34	0.34	0.00	0.34	0.00	0.00
Synoviocyte, donor3	11440-118H9	19.88	8.94	5.59	3.80	2.01	0.22	0.22	0.00	0.22	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	29.30	14.65	6.43	12.51	7.15	0.00	1.43	0.36	0.36	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	53.52	5.95	11.89	5.95	1.98	0.00	0.00	1.98	1.98	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	36.35	13.43	8.10	11.11	6.25	0.00	0.23	0.00	0.46	0.93
Tracheal Epithelial Cells, donor1	11292-117A5	27.96	8.75	9.10	9.68	6.09	7.31	7.74	0.72	1.51	1.29
Tracheal Epithelial Cells, donor2	11369-118A1	21.26	8.89	8.89	7.73	4.25	3.09	10.05	0.77	0.77	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	24.62	6.30	6.87	4.58	6.87	4.58	4.58	0.00	0.57	2.86
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	34.94	15.38	12.18	9.35	4.43	2.58	1.72	1.72	1.23	0.74
Urethra, donor2	10319-105A4	26.98	17.98	1.80	8.99	1.80	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	24.71	8.50	10.10	7.17	7.70	20.99	14.61	6.11	2.39	1.86
Urothelial Cells, donor2	11600-120H7	16.42	9.21	5.61	6.01	4.41	13.22	14.02	4.41	1.20	0.80
Urothelial Cells, donor3	11681-122H7	21.32	7.33	6.88	6.88	5.27	6.19	8.02	2.52	0.23	1.15
Urothelial cells, donor0	11216-116B1	40.57	4.68	15.83	10.25	6.69	42.13	25.41	7.36	2.23	1.11
Whole blood (ribopure), donor090309, donation1	12179-129A1	1921.93	32.92	171.73	769.66	129.91	62.28	6.23	161.94	256.26	28.47
Whole blood (ribopure), donor090309, donation2	12180-129A2	2241.63	34.31	238.75	953.55	182.99	91.50	7.15	190.14	251.61	32.88
Whole blood (ribopure), donor090309, donation3	12181-129A3	1158.21	22.59	121.16	510.65	98.57	31.49	6.85	86.25	158.12	45.18
Whole blood (ribopure), donor090325, donation1	12176-128I7	509.96	19.28	73.69	251.37	54.06	28.58	2.75	52.68	38.22	8.95
Whole blood (ribopure), donor090325, donation2	12177-128I8	458.43	20.92	78.44	263.79	41.83	23.82	2.91	47.06	34.86	7.55
Whole blood (ribopure), donor090612, donation1	12182-129A4	1452.53	39.57	144.73	622.66	106.21	54.14	2.08	125.99	152.02	10.41
Whole blood (ribopure), donor090612, donation2	12183-129A5	1712.60	33.04	163.37	685.59	111.05	57.82	8.26	135.83	179.89	22.03
Whole blood (ribopure), donor090612, donation3	12184-129A6	1515.41	21.91	140.59	668.24	106.81	35.60	6.39	99.51	211.79	53.86
Wilms' tumor cell line:G-401	10809-111A8	21.34	10.36	5.55	7.40	9.87	2.47	3.08	1.23	0.99	1.60
Wilms' tumor cell line:HFWT	10597-108E3	29.04	0.88	4.40	4.40	4.40	0.88	0.88	1.76	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	34.36	20.39	10.89	19.83	10.33	1.12	2.51	1.12	1.96	0.56
achilles tendon, donor2	10292-104G4	26.86	6.20	8.27	4.13	6.20	0.00	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	10.96	6.37	2.80	3.57	5.61	28.81	8.92	5.61	0.00	2.29
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	13.23	6.27	1.16	7.89	7.89	0.23	0.46	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	6.77	15.19	1.42	3.44	10.21	0.83	3.32	0.00	0.00	0.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	8.71	18.78	1.09	8.16	14.15	0.00	0.82	0.00	0.00	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	5.06	14.34	0.56	2.81	7.59	0.84	0.84	0.00	0.00	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	5.71	9.52	3.17	2.11	3.60	2.11	0.63	0.21	0.21	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	24.77	3.54	32.94	4.08	16.06	0.54	0.82	0.27	0.00	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	9.69	6.61	7.49	3.08	0.88	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	15.52	15.93	11.03	5.72	6.13	4.08	0.41	0.00	0.41	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	6.60	17.47	0.39	4.66	9.32	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.18	7.91	0.00	0.37	1.66	0.00	0.00	0.00	0.00	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	15.60	3.90	7.80	0.00	3.90	3.90	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	20.91	10.22	13.71	6.51	5.34	3.25	2.09	1.16	0.00	1.16
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	3.37	12.95	0.52	1.81	4.92	0.26	0.00	0.00	0.00	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	2.63	11.40	0.29	2.34	4.97	0.00	0.00	0.00	0.00	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	1.39	8.83	0.46	0.00	1.39	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	3.29	6.58	3.29	1.23	3.29	0.00	0.00	0.00	0.00	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	1.84	10.13	0.31	1.23	0.92	0.00	0.00	0.00	0.00	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	0.85	14.93	0.00	0.43	1.28	0.00	0.00	0.00	0.00	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	1.21	16.98	0.61	1.82	0.61	0.00	0.00	0.00	0.30	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	0.72	19.98	0.00	0.72	3.85	0.00	0.00	0.00	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	1.78	21.61	0.45	0.67	3.34	0.00	0.00	0.00	0.22	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	25.68	7.34	15.01	8.34	52.37	16.68	5.34	4.67	2.33	2.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	9.29	0.00	3.72	5.57	24.16	42.74	1.86	0.00	0.00	5.57
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	39.93	14.31	27.12	10.17	26.74	6.78	3.01	7.53	1.13	2.64
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	27.48	5.67	10.47	9.59	10.03	0.87	0.44	0.44	0.00	1.31
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	31.87	1.87	3.75	15.00	3.75	0.00	1.87	3.75	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	28.02	9.18	4.00	23.08	13.19	0.24	0.47	0.00	1.41	0.71
adipose tissue, adult, pool1	10010-101C1	21.87	9.62	31.33	5.27	4.65	2.33	2.02	0.31	0.62	1.40
adipose, donor1	10184-103D4	14.07	42.81	2.35	9.38	9.38	1.17	8.80	0.59	0.00	1.17
adipose, donor2	10185-103D5	13.79	25.55	0.41	8.92	11.76	0.41	0.41	0.00	0.00	0.81
adipose, donor3	10186-103D6	11.71	16.61	0.82	4.90	13.34	0.54	2.45	0.27	0.27	0.54
adipose, donor4	10187-103D7	7.80	25.14	0.00	2.60	3.47	0.87	2.60	0.00	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	3.63	17.68	0.16	3.79	5.52	0.00	0.00	0.16	0.16	0.00
adrenal gland, adult, pool1	10081-102A9	7.28	14.55	3.64	0.00	7.28	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	4.00	11.87	0.00	2.27	6.54	20.41	0.67	0.13	0.13	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	78.96	8.93	43.23	17.86	49.31	18.22	14.29	10.00	6.79	4.64
amniotic membrane cells, donor1	12235-129G3	21.10	15.77	3.94	10.67	1.62	0.23	1.39	2.78	0.93	0.70
amniotic membrane cells, donor2	12236-129G4	11.50	17.58	3.72	6.09	2.70	1.01	1.35	3.04	0.68	1.35
amniotic membrane cells, donor3	12237-129G5	21.51	16.50	4.12	4.71	0.59	0.00	0.88	1.18	0.59	0.59
amygdala - adult, donor10196	10167-103B5	18.97	56.92	5.93	4.74	5.93	0.00	2.37	0.00	1.19	0.00
amygdala, adult, donor10252	10151-102I7	34.27	34.27	9.53	7.71	11.76	0.61	0.81	0.61	0.61	1.42
amygdala, newborn, donor10223	10360-105E9	7.42	26.79	3.87	3.87	9.04	2.90	1.61	0.32	0.97	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	43.29	6.11	6.37	14.52	7.89	1.27	0.76	0.13	1.27	1.66
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	8.60	15.22	0.44	2.87	3.53	0.22	0.00	0.00	0.22	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	25.05	19.04	2.67	21.71	19.71	0.67	3.34	0.00	1.00	1.67
aorta, adult, pool1	10052-101G7	60.02	12.75	17.46	7.06	1.96	2.55	1.18	0.39	0.98	0.78
appendix, adult	10189-103D9	11.64	11.64	6.60	5.43	2.33	4.66	2.33	0.39	0.00	0.78
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	14.79	14.10	1.03	9.29	20.98	0.00	2.41	0.00	0.00	3.78
artery, adult	10190-103E1	16.30	6.79	5.43	1.36	2.72	2.72	0.00	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	13.91	10.29	5.07	8.98	9.85	1.74	3.77	2.90	0.29	1.16
b cell line:RPMI1788	10427-106D4	4.76	9.07	0.89	2.97	3.27	33.31	17.55	3.87	0.59	0.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	11.93	10.54	6.10	7.21	2.22	1.11	0.28	0.00	0.55	1.66
bile duct carcinoma cell line:HuCCT1	10432-106D9	58.35	14.79	28.38	16.77	18.95	22.03	17.96	5.16	7.54	7.64
bile duct carcinoma cell line:TFK-1	10496-107C1	55.74	12.05	25.61	15.90	9.04	4.85	4.18	1.51	7.36	1.84
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	0.56	8.95	0.00	0.56	0.56	0.00	0.00	0.00	0.00	0.56
bladder, adult, pool1	10011-101C2	20.86	6.84	5.21	5.87	1.41	0.65	0.98	0.33	0.65	0.43
blood, adult, pool1	10053-101G8	1149.39	11.07	101.87	374.27	46.51	22.15	2.21	35.43	37.65	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	47.96	4.28	23.12	8.56	11.13	3.43	0.00	0.00	5.99	1.71
bone marrow, adult	10192-103E3	19.57	9.45	11.47	3.37	2.70	2.02	0.00	0.67	0.67	2.70
brain, adult, donor1	10084-102B3	34.85	34.85	13.33	4.10	8.20	2.05	0.00	0.00	0.00	2.05
brain, adult, pool1	10012-101C3	24.83	37.19	11.58	5.01	5.57	1.11	1.45	0.22	0.45	0.78
brain, fetal, pool1	10085-102B4	24.04	58.77	5.34	16.03	10.69	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	9.91	15.53	3.96	2.97	1.32	0.00	0.99	0.66	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	57.29	27.46	21.84	23.97	8.99	0.25	3.00	3.25	3.37	3.99
breast, adult, donor1	10080-102A8	46.09	7.58	23.99	8.21	3.79	1.26	1.26	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	30.87	17.66	4.95	13.59	8.51	2.16	3.43	0.13	0.00	1.14
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	55.97	9.59	6.49	17.01	24.12	3.09	1.55	0.31	0.31	2.78
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	6.45	22.79	1.15	3.45	2.99	0.69	0.46	0.23	0.00	0.46
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	4.36	11.62	0.48	3.15	2.18	0.00	0.00	0.00	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	4.23	14.11	0.00	4.23	15.99	0.00	0.00	0.47	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	11.70	12.14	2.30	4.81	10.83	0.00	0.98	0.22	0.00	0.77
carcinoid cell line:SK-PN-DW	10719-109I8	0.95	11.09	0.00	0.95	2.54	0.00	0.00	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	9.05	13.58	0.53	2.66	18.10	0.00	0.80	0.27	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	27.63	32.24	8.06	4.61	2.30	1.15	1.15	0.00	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	25.77	35.81	8.03	4.52	8.53	1.00	3.18	1.00	0.17	1.34
caudate nucleus, adult, donor10258	10379-105H1	6.88	42.79	6.88	4.58	7.64	0.00	1.53	0.76	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	7.32	21.61	5.49	3.66	10.25	2.93	0.37	0.00	0.37	0.37
cerebellum - adult, donor10196	10173-103C2	32.05	34.96	14.57	20.39	17.48	2.91	5.83	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	54.66	31.39	13.24	18.15	18.36	3.20	4.91	3.63	0.21	2.56
cerebellum, adult, pool1	10083-102B2	25.87	25.18	6.55	5.17	7.93	0.69	2.76	0.34	0.34	1.72
cerebellum, newborn, donor10223	10357-105E6	8.30	11.62	8.30	3.32	8.30	0.83	3.32	0.00	0.00	0.83
cerebral meninges, adult	10188-103D8	12.86	37.06	5.04	3.53	3.78	0.76	0.50	0.25	0.50	1.26
cerebrospinal fluid, donor2	10294-104G6	29.24	4.39	5.85	5.12	0.73	0.73	0.00	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	19.70	33.93	2.01	11.50	2.01	0.43	0.58	0.58	0.72	0.43
cervical cancer cell line:ME-180	10553-107I4	48.22	15.25	17.23	14.58	3.48	11.27	10.61	3.31	5.14	5.63
cervix, adult, pool1	10013-101C4	16.27	14.80	10.08	4.30	3.04	0.73	0.63	0.10	0.52	0.73
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	39.99	13.24	20.76	13.24	2.93	0.98	0.28	0.70	1.67	0.84
chondrosarcoma cell line:SW 1353	10700-109G7	23.51	5.23	0.00	10.45	9.14	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	10.94	19.76	2.36	8.58	6.96	1.24	2.36	9.20	0.50	0.75
choriocarcinoma cell line:SCH	10785-110H2	14.66	11.58	1.60	7.89	4.93	2.34	6.53	10.35	0.37	1.23
choriocarcinoma cell line:T3M-3	10618-108G6	7.12	10.91	1.42	5.46	4.27	0.24	0.95	3.32	0.47	1.90
chorionic membrane cells, donor1	12238-129G6	9.69	15.67	3.99	3.99	2.85	1.14	1.42	0.57	0.28	1.42
chorionic membrane cells, donor2	12239-129G7	24.06	10.44	9.94	6.56	2.88	3.88	4.97	2.29	2.59	1.49
chorionic membrane cells, donor3	12240-129G8	12.64	22.53	7.14	4.40	1.65	0.00	0.55	1.10	0.00	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	9.09	7.07	1.01	5.05	4.04	0.00	3.03	1.01	0.00	5.05
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	11.33	8.07	9.41	4.03	2.50	0.58	0.19	0.19	0.19	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	27.03	7.39	8.87	7.18	3.17	1.27	0.21	1.27	0.84	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	11.04	7.70	3.34	5.91	17.46	33.64	4.37	2.05	0.26	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	11.85	6.77	3.39	7.50	19.11	43.78	8.47	6.05	0.73	1.94
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	12.62	8.76	3.26	6.52	18.94	46.83	6.11	4.28	0.61	2.65
chronic myelogenous leukemia cell line:K562	10454-106G4	10.31	7.66	2.06	10.31	16.20	33.57	1.18	4.71	0.29	1.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	27.63	8.86	10.69	8.08	11.99	6.78	2.35	2.87	0.52	1.04
clear cell carcinoma cell line:JHOC-5	10638-108I8	31.54	12.11	4.80	28.12	54.40	11.43	11.66	2.74	1.60	9.14
clear cell carcinoma cell line:TEN	10636-108I6	57.95	32.10	16.14	21.17	26.89	13.19	9.02	2.08	2.78	5.21
colon carcinoma cell line:CACO-2	10513-107D9	77.98	19.59	20.13	27.46	49.97	21.05	21.42	8.42	5.31	4.39
colon carcinoma cell line:COLO-320	10420-106C6	1.14	18.24	0.38	3.04	5.32	0.00	0.00	0.00	0.00	0.38
colon, adult, donor1	10082-102B1	20.23	11.90	3.57	10.71	3.57	1.19	0.00	0.00	0.00	1.19
colon, adult, pool1	10014-101C5	21.15	14.57	6.11	9.40	1.29	1.76	0.24	0.24	0.12	0.82
colon, fetal, donor1	10070-101I7	27.19	6.80	4.94	7.42	0.62	1.24	1.24	1.85	0.62	0.62
common myeloid progenitor CMP, donor1	12130-128D6	22.92	32.08	0.00	9.17	9.17	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	4.25	7.22	3.40	0.85	8.92	136.40	0.85	69.69	6.80	2.12
cord blood derived cell line:COBL-a 24h infection	10453-106G3	3.02	6.64	3.02	0.60	7.24	127.08	0.30	29.13	1.36	1.81
cord blood derived cell line:COBL-a untreated	10449-106F8	2.82	7.90	2.96	1.27	10.58	140.17	0.71	37.51	1.55	3.81
corpus callosum, adult, pool1	10042-101F6	74.19	30.96	26.20	13.05	9.40	2.10	0.88	0.77	0.55	1.55
cruciate ligament, donor2	10295-104G7	31.61	11.35	12.97	3.24	1.62	0.00	0.00	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	22.47	6.42	11.24	4.01	3.21	0.80	1.61	0.00	0.00	0.00
diencephalon, adult	10193-103E4	20.16	24.00	7.92	2.88	6.00	0.00	0.24	0.24	0.00	1.20
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	7.58	8.50	1.15	2.53	6.66	2.53	5.97	0.46	0.69	1.38
ductal cell carcinoma cell line:KLM-1	10438-106E6	18.46	26.67	6.67	17.44	11.28	3.59	1.54	3.08	1.54	1.80
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	32.50	3.61	22.87	5.30	5.78	24.07	10.83	1.44	1.93	2.41
ductus deferens, adult	10196-103E7	12.46	19.44	6.48	3.49	2.99	0.50	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	46.09	15.84	4.32	11.52	4.32	0.00	2.88	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	16.92	16.18	5.89	3.68	6.62	1.47	0.00	0.00	0.00	2.21
dura mater, adult, donor1	10041-101F5	32.70	13.54	28.74	6.28	6.36	2.97	1.90	0.41	1.40	0.91
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	0.67	11.77	0.44	0.44	16.21	0.44	0.00	0.44	0.44	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	0.43	15.48	0.00	0.57	3.30	0.00	0.00	0.00	0.00	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	88.18	6.78	16.65	18.50	33.30	1.85	3.70	1.23	1.23	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	25.43	9.08	6.05	13.92	18.47	2.72	2.42	1.21	0.61	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	62.68	9.57	10.81	14.20	28.71	1.85	3.40	0.31	0.93	0.31
embryonic pancreas cell line:2C6	10603-108E9	68.30	6.57	6.57	22.33	43.34	0.00	5.25	0.00	2.63	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	66.37	7.71	29.83	19.78	26.48	31.17	17.77	13.41	7.04	2.35
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	52.56	7.97	15.22	14.14	24.83	8.16	6.71	1.27	1.99	1.99
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	12.54	11.90	2.41	8.84	13.67	1.29	2.09	1.29	0.48	2.25
epidermoid carcinoma cell line:A431	10426-106D3	23.45	12.89	8.34	13.23	6.11	2.22	2.45	0.78	1.33	0.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	35.64	16.72	10.01	18.81	17.49	9.02	13.09	4.18	3.19	4.40
epididymis, adult	10197-103E8	11.09	13.81	3.56	2.51	2.09	0.84	0.84	0.21	0.00	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	43.47	8.69	17.92	13.84	7.98	11.35	4.61	1.24	4.08	3.02
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	9.04	8.65	7.47	1.57	1.57	2.36	0.79	0.39	0.00	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	5.50	13.24	0.79	5.90	10.62	0.26	1.70	0.26	0.26	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	8.76	17.91	2.07	6.10	10.83	0.30	1.28	0.20	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	6.05	16.58	1.46	5.15	9.63	0.22	1.34	0.45	0.11	1.01
esophagus, adult, pool1	10015-101C6	22.40	12.74	7.11	5.95	1.17	1.06	1.27	0.11	0.42	0.32
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	12.77	15.28	6.26	2.13	4.13	41.33	5.26	2.38	0.63	1.38
eye - muscle inferior rectus, donor1	10272-104E2	31.39	4.83	19.32	0.00	0.00	2.41	0.00	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	16.83	10.52	4.21	2.10	2.10	0.00	0.00	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	43.16	2.98	7.44	5.95	0.00	2.98	0.00	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	33.25	5.73	9.17	1.15	6.88	0.00	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	5.83	10.20	0.00	1.46	7.29	0.00	2.91	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	30.25	9.15	5.85	6.36	5.85	0.51	5.34	1.02	0.25	2.03
fibrosarcoma cell line:HT-1080	10758-110E2	23.08	5.77	6.80	8.59	3.72	1.54	2.31	1.28	0.38	1.28
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	6.65	12.58	1.42	4.51	7.36	0.00	0.47	0.00	0.24	0.47
frontal lobe, adult, pool1	10040-101F4	21.02	60.33	7.60	7.51	9.38	0.66	1.03	0.28	0.47	1.31
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	22.22	21.92	11.11	9.31	12.01	6.00	12.01	5.70	2.10	3.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	21.30	6.49	13.08	13.62	2.10	9.97	6.77	6.22	0.82	0.73
gall bladder, adult	10198-103E9	32.35	14.49	16.42	6.28	4.83	2.90	0.97	0.72	2.90	1.93
gamma delta positive T cells, donor1	11937-126A2	20.94	8.59	4.83	6.98	9.13	20.94	1.07	0.00	0.00	2.68
gamma delta positive T cells, donor2	11938-126A3	26.52	7.84	7.10	12.33	8.22	13.82	0.75	0.37	0.37	2.61
gastric adenocarcinoma cell line:MKN1	10614-108G2	17.74	26.40	4.65	6.13	6.76	4.01	2.75	2.75	1.48	2.32
gastric adenocarcinoma cell line:MKN45	10612-108F9	80.46	18.57	19.34	20.50	9.28	9.28	12.96	1.74	3.09	5.22
gastric cancer cell line:AZ521	10549-107H9	7.21	10.17	2.30	6.39	20.49	1.48	1.64	0.66	0.49	1.31
gastric cancer cell line:GSS	10560-108A2	30.20	21.97	5.49	13.73	51.25	5.49	6.41	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	8.00	6.63	1.60	2.51	7.08	0.00	0.69	0.46	0.00	1.60
giant cell carcinoma cell line:LU65	10487-107B1	53.24	6.88	10.21	17.44	15.38	4.25	2.41	1.84	3.56	2.18
giant cell carcinoma cell line:Lu99B	10433-106E1	21.13	10.08	8.26	6.30	3.08	4.20	4.20	0.84	1.12	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	9.48	14.97	1.25	5.99	5.74	0.50	0.75	0.50	1.25	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	31.88	6.12	20.05	10.03	19.74	7.39	4.64	1.79	1.27	2.85
glioblastoma cell line:A172, tech_rep2	10444-106F3	37.22	7.58	20.36	9.83	19.38	7.58	5.76	0.98	1.26	1.54
glioblastoma cell line:T98G	10485-107A8	21.08	8.94	4.64	8.50	3.31	0.33	0.22	0.22	0.22	0.55
glioma cell line:GI-1	10413-106B8	2.93	13.18	1.46	1.76	4.98	0.00	0.00	0.00	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	61.96	22.60	13.85	9.48	10.20	2.19	0.00	0.73	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	92.27	18.80	31.49	12.94	13.67	1.22	1.95	1.46	1.46	2.93
globus pallidus, adult, donor10258	10367-105F7	34.23	17.80	13.69	4.11	2.74	0.00	0.00	0.00	1.37	1.37
globus pallidus, newborn, donor10223	10364-105F4	11.19	12.26	13.32	3.20	11.72	0.53	0.00	0.53	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	0.00	31.81	0.00	4.89	7.34	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	10.93	10.93	0.00	10.93	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	25.92	5.76	3.84	6.40	3.20	0.96	0.00	0.00	0.32	1.60
hIPS +CCl2, biol_rep1	14383-156B9	9.64	14.23	1.84	5.51	7.80	0.00	4.13	0.92	0.46	0.46
hIPS +CCl2, biol_rep2	14384-156C1	9.60	13.26	3.66	4.12	6.40	0.46	1.37	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	15.46	12.88	1.29	5.15	14.81	1.29	0.00	0.00	0.00	0.64
hIPS, biol_rep1	14380-156B6	4.31	15.81	1.44	4.31	12.94	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	6.17	13.03	0.00	6.86	10.29	1.37	0.00	1.37	0.00	0.00
hIPS, biol_rep3	14382-156B8	13.24	35.31	6.62	1.10	8.83	0.00	2.21	0.00	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	7.18	8.62	2.87	4.31	9.19	48.27	6.90	24.71	8.33	2.87
heart - mitral valve, adult	10205-103F7	20.03	7.77	9.87	3.59	2.99	1.79	0.30	0.60	1.49	1.49
heart - pulmonic valve, adult	10206-103F8	15.43	8.89	12.29	3.14	1.57	0.52	0.00	0.26	0.00	0.78
heart - tricuspid valve, adult	10207-103F9	40.80	3.33	33.31	5.83	12.49	9.99	2.50	1.67	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	36.93	22.65	10.81	11.84	6.12	1.63	3.06	1.22	0.41	1.22
heart, adult, diseased, donor1	10051-101G6	36.20	14.48	15.76	13.20	4.68	2.98	1.28	1.28	0.43	0.85
heart, adult, pool1	10016-101C7	29.44	10.12	12.19	11.04	2.53	2.07	0.69	0.46	0.00	0.46
heart, fetal, pool1	10046-101G1	60.48	7.39	22.08	19.00	6.57	4.62	2.26	2.88	1.64	0.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	12.65	5.55	2.16	3.70	1.85	0.00	0.31	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	48.76	3.57	7.14	8.32	7.14	1.19	0.00	0.00	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	83.98	13.04	18.34	24.75	89.39	15.14	11.82	5.75	8.84	12.82
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	89.33	15.29	18.57	25.85	75.86	12.99	9.83	6.19	9.83	15.29
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	82.66	15.56	19.10	23.04	94.89	16.57	11.72	5.05	11.22	14.45
hepatoma cell line:Li-7	10484-107A7	47.82	9.12	22.13	10.57	9.68	4.89	2.89	0.78	2.34	1.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	4.32	9.75	0.10	3.12	4.12	1.21	2.21	0.10	0.10	0.00
hippocampus - adult, donor10196	10169-103B7	17.03	29.34	7.57	6.62	5.68	4.73	1.89	0.95	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	50.41	29.80	14.49	7.14	15.10	2.04	1.02	0.61	1.63	2.86
hippocampus, adult, donor10258	10374-105G5	3.49	44.82	5.48	4.48	6.97	0.00	0.50	0.00	0.00	1.00
hippocampus, newborn, donor10223	10363-105F3	5.99	32.78	7.05	1.41	8.11	0.00	0.00	0.35	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	6.71	18.92	1.83	3.66	5.49	0.00	3.66	0.00	0.61	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	5.89	9.82	0.20	4.91	9.03	0.00	1.37	0.20	0.39	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	4.06	13.96	0.51	2.29	10.16	0.25	1.52	0.00	0.00	1.27
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	9.59	23.68	0.00	6.20	10.71	0.00	1.69	0.00	0.00	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	11.88	22.72	0.77	6.46	9.55	0.26	2.32	0.26	0.00	2.07
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	4.18	28.47	2.28	3.04	13.29	0.76	1.14	0.38	0.38	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	6.42	17.23	1.46	3.21	15.77	0.58	0.88	0.88	0.00	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	8.40	17.67	0.86	6.03	19.17	0.22	1.29	1.08	0.00	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	7.51	21.69	1.67	4.17	19.60	0.00	0.42	0.42	0.00	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	3.79	22.50	2.60	2.37	16.81	1.66	1.66	0.24	0.00	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	9.32	24.43	2.73	4.34	17.20	1.45	0.48	0.64	0.16	0.96
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	2.69	25.59	0.67	2.02	22.89	2.69	0.00	0.00	0.00	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	13.14	12.52	1.72	7.20	14.08	0.47	1.88	0.63	0.16	1.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	12.77	20.14	0.49	5.90	12.28	0.49	3.93	0.98	0.00	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	5.24	19.20	0.00	3.49	6.11	0.87	3.49	1.75	0.87	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	21.95	31.12	1.72	11.07	18.71	0.57	2.29	0.38	0.00	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	23.55	36.63	1.74	12.21	19.62	1.74	0.87	0.87	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	21.49	43.48	1.00	8.50	18.49	1.50	4.50	1.50	0.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	12.06	21.67	1.13	6.59	12.43	0.38	0.19	0.38	0.00	1.13
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	17.73	31.38	1.36	5.91	17.28	0.00	0.91	0.00	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	12.22	28.50	0.63	4.70	17.23	0.31	1.25	0.31	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	16.00	22.86	3.27	8.33	26.62	1.14	1.31	0.16	0.16	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	15.68	20.90	2.90	5.52	25.55	0.29	1.16	0.58	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	11.36	28.10	3.59	7.47	23.02	0.60	0.60	0.90	0.30	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	9.42	16.44	1.66	6.65	9.24	0.92	2.40	1.48	0.37	0.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	7.42	13.69	1.14	9.41	7.70	0.57	4.28	1.43	0.00	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	11.43	20.82	0.41	4.08	7.76	0.00	4.49	0.41	0.41	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	15.14	20.42	2.11	2.46	9.15	3.17	4.58	1.06	0.00	3.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	12.99	16.47	0.32	4.75	9.19	1.90	1.90	0.32	0.32	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	10.29	23.30	4.24	6.96	8.17	1.21	1.51	2.12	0.00	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	7.76	16.03	2.07	4.65	14.48	0.00	1.03	0.52	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	7.31	18.60	0.66	5.31	15.28	0.00	1.33	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	3.08	18.98	0.26	1.28	12.31	0.26	0.51	0.00	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	10.74	15.59	4.35	4.09	12.27	1.53	1.02	1.02	0.26	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	7.57	21.96	0.76	3.79	15.14	0.00	0.00	1.51	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	11.09	15.46	2.35	7.06	15.12	0.67	1.01	1.01	0.67	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	9.18	15.94	2.42	6.52	9.42	0.97	2.42	0.72	0.24	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	6.24	14.71	2.23	4.01	7.58	0.45	1.78	0.45	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	12.20	15.12	0.00	4.88	8.29	1.46	3.90	0.98	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	10.70	22.92	1.22	6.72	9.17	0.00	2.14	0.31	0.00	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	6.51	55.31	0.00	3.25	0.00	6.51	13.01	0.00	6.51	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	9.60	23.17	3.31	5.96	5.63	1.32	2.32	0.33	0.00	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	7.66	30.10	1.09	2.74	18.06	0.55	0.55	0.00	0.00	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	6.51	20.27	0.36	2.90	11.22	0.36	0.36	1.09	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	3.91	19.93	0.71	1.78	11.03	0.36	0.36	0.00	0.00	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	7.16	20.29	3.58	2.39	13.13	0.00	1.19	0.00	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	8.40	30.20	4.06	5.28	19.23	1.08	1.76	1.08	0.27	1.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	6.20	19.13	1.35	3.23	17.78	2.16	0.54	0.00	0.27	0.81
immature langerhans cells, donor1	11904-125F5	6.78	12.35	9.93	0.48	2.18	4.36	1.70	0.48	0.97	0.24
immature langerhans cells, donor2	11905-125F6	1.58	7.92	3.17	1.58	3.17	1.58	1.58	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	21.77	74.10	10.41	7.38	9.37	0.19	0.76	0.28	0.38	1.04
keratoacanthoma cell line:HKA-1	10791-110H8	12.68	24.39	0.98	8.13	2.93	0.00	0.65	0.00	0.33	0.00
kidney, adult, pool1	10017-101C8	37.55	17.82	22.73	11.92	8.61	8.31	3.20	4.41	2.50	3.40
kidney, fetal, pool1	10045-101F9	50.01	18.25	15.07	13.79	9.34	9.12	5.80	4.88	2.55	2.26
large cell lung carcinoma cell line:IA-LM	10509-107D5	33.23	8.81	16.19	16.62	7.81	4.69	4.69	0.43	2.27	1.70
large cell lung carcinoma cell line:NCI-H460	10839-111E2	5.25	9.26	0.55	2.90	4.01	0.00	0.41	0.00	0.00	0.97
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	26.61	4.22	8.26	8.44	11.19	8.99	9.73	5.14	3.67	2.20
left atrium, adult, donor1	10079-102A7	15.26	6.54	7.08	1.09	2.18	0.00	0.54	0.54	0.54	0.00
left ventricle, adult, donor1	10078-102A6	25.28	3.54	11.63	7.58	5.56	2.02	0.51	0.00	0.51	0.51
leiomyoblastoma cell line:G-402	10721-110A1	13.13	10.94	1.92	2.19	8.48	0.00	0.55	0.00	0.00	0.55
leiomyoma cell line:10964C	10569-108B2	17.60	16.17	19.04	4.31	1.44	3.23	1.08	0.36	1.80	1.80
leiomyoma cell line:15242A	10570-108B3	10.33	6.52	7.61	2.72	0.54	2.72	1.09	1.09	1.09	0.54
leiomyoma cell line:15425	10571-108B4	17.73	10.44	8.74	4.61	3.64	0.49	1.70	0.49	0.97	1.70
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	12.70	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	11.50	7.32	3.14	3.14	12.55	2.09	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	63.99	5.55	28.69	13.58	9.44	43.80	8.97	8.38	2.95	2.60
liposarcoma cell line:KMLS-1	10782-110G8	12.97	11.09	2.19	2.66	1.87	0.00	0.47	0.31	0.31	0.16
liposarcoma cell line:SW 872	10726-110A6	17.06	7.43	2.92	11.57	7.68	0.12	0.61	0.12	0.24	0.24
liver, adult, pool1	10018-101C9	29.01	11.83	14.59	7.29	3.40	1.30	0.97	0.81	1.78	2.76
liver, fetal, pool1	10086-102B5	81.84	3.76	11.29	22.58	11.29	8.47	0.94	9.41	4.70	2.82
locus coeruleus - adult, donor10196	10182-103D2	38.50	17.21	11.52	6.12	9.62	2.62	1.02	0.87	0.29	1.31
locus coeruleus, adult, donor10252	10165-103B3	46.88	25.28	12.18	8.67	14.76	0.92	0.37	0.55	0.92	1.48
locus coeruleus, adult, donor10258	10375-105G6	17.21	23.98	5.92	2.82	2.54	0.00	0.56	0.56	0.56	2.82
locus coeruleus, newborn, donor10223	10362-105F2	15.56	16.40	18.93	2.94	7.15	3.36	2.10	0.00	1.26	0.00
lung adenocarcinoma cell line:A549	10499-107C4	39.86	7.06	10.38	11.90	11.21	6.23	6.23	1.25	2.08	1.52
lung adenocarcinoma cell line:PC-14	10408-106B3	13.79	12.41	4.83	6.89	9.65	0.00	0.00	0.69	0.00	2.07
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	36.78	9.49	8.70	10.94	17.93	1.19	1.98	1.19	1.98	1.19
lung, adult, pool1	10019-101D1	48.20	8.51	20.20	14.53	6.85	10.99	3.43	1.42	3.07	1.18
lung, fetal, donor1	10068-101I5	90.76	18.27	34.82	21.41	15.98	15.41	3.42	11.99	6.56	3.42
lung, right lower lobe, adult, donor1	10075-102A3	32.53	11.91	19.70	5.50	2.75	3.21	1.83	0.46	0.46	0.46
lymph node, adult, donor1	10077-102A5	15.62	6.15	12.31	3.31	2.84	1.89	1.42	0.00	0.47	0.95
lymphangiectasia cell line:DS-1	10727-110A7	6.36	7.01	0.88	3.51	3.29	1.97	5.48	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	6.79	9.21	2.72	2.41	4.83	48.15	37.43	5.13	0.75	10.11
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	46.72	20.39	19.54	22.09	26.33	6.80	5.95	4.25	4.25	1.70
mature adipocyte, donor1	12231-129F8	2.66	11.10	3.11	2.22	0.44	4.44	0.44	0.00	0.44	0.44
mature adipocyte, donor2	12232-129F9	7.26	14.32	6.64	1.04	3.32	9.34	1.04	0.62	0.62	0.21
mature adipocyte, donor3	12233-129G1	4.74	10.19	3.08	0.71	2.13	2.84	0.24	0.00	0.00	0.71
mature adipocyte, donor4	12234-129G2	6.05	15.00	2.37	1.05	2.63	2.37	0.00	0.00	0.00	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	64.09	30.74	10.25	39.07	37.41	3.81	5.72	0.95	0.48	4.05
medial frontal gyrus - adult, donor10196	10170-103B8	19.18	38.35	12.41	2.26	4.51	2.26	1.13	2.26	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	42.67	37.33	9.38	6.80	13.43	1.10	1.84	1.10	0.74	2.76
medial frontal gyrus, adult, donor10258	10368-105F8	8.26	44.79	4.45	1.91	6.04	0.64	0.00	0.00	0.00	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	6.40	49.05	7.68	0.85	5.54	5.97	2.56	0.00	0.85	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	19.91	51.13	9.28	5.40	8.94	2.87	1.18	0.84	0.84	5.06
medial temporal gyrus, adult, donor10252	10156-103A3	47.75	36.08	19.95	7.22	14.64	0.64	0.85	0.42	0.00	2.33
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	5.78	32.75	5.78	1.93	5.78	0.00	0.00	0.00	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	86.12	0.00	0.00	0.00	0.00	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	7.90	42.35	4.31	3.23	11.49	4.67	1.08	1.08	0.36	0.36
medulla oblongata - adult, donor10196	10174-103C3	50.62	14.93	13.63	9.73	5.19	7.14	5.19	0.65	3.89	1.30
medulla oblongata, adult, donor10252	10155-103A2	75.23	19.66	14.86	10.99	17.49	3.10	3.87	1.55	4.33	2.48
medulla oblongata, adult, pool1	10038-101F2	39.83	26.53	24.32	7.02	6.20	2.69	1.06	1.06	0.65	0.90
medulla oblongata, newborn, donor10223	10361-105F1	13.89	11.11	11.11	2.43	10.42	1.04	0.35	0.35	1.04	1.74
medulloblastoma cell line:D283 Med	10838-111E1	95.21	18.82	9.52	17.27	33.88	7.31	8.64	1.99	2.88	6.20
medulloblastoma cell line:ONS-76	10759-110E3	29.10	11.37	5.38	13.82	17.24	1.47	4.16	0.73	1.10	0.86
melanoma cell line:COLO 679	10514-107E1	6.90	6.76	5.32	2.73	4.46	1.44	0.14	0.14	0.14	0.43
melanoma cell line:G-361	10465-106H6	8.42	17.92	2.71	4.89	6.24	0.00	0.00	0.00	0.00	0.54
meningioma cell line:HKBMM	10691-109F7	18.09	2.17	4.34	6.15	3.62	4.88	3.08	1.09	0.72	3.08
merkel cell carcinoma cell line:MKL-1	10843-111E6	37.01	28.20	10.57	14.98	55.51	32.60	47.58	5.29	2.64	17.62
merkel cell carcinoma cell line:MS-1	10844-111E7	15.55	23.85	4.41	7.26	15.81	2.59	19.18	0.52	0.26	4.67
mesenchymal precursor cell - adipose, donor1	11747-123G1	15.65	10.43	5.37	3.38	3.07	0.31	0.46	0.15	0.31	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	7.63	7.63	4.36	1.82	2.36	0.00	0.00	0.18	0.18	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	11.18	10.35	7.87	2.90	4.14	1.24	0.00	0.41	0.83	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	25.99	7.87	18.12	6.32	2.67	0.84	1.12	0.14	1.12	0.98
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	25.03	9.82	9.82	3.85	2.50	0.96	0.58	0.39	2.50	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	40.26	10.41	13.19	8.33	6.25	2.78	0.00	2.08	4.16	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	38.62	8.75	26.95	2.40	4.12	2.57	1.54	0.69	2.23	0.86
mesenchymal precursor cell - cardiac, donor2	11753-123G7	22.66	9.78	12.19	3.34	2.88	1.84	0.35	0.23	1.38	1.04
mesenchymal precursor cell - cardiac, donor3	11754-123G8	13.53	10.61	5.70	3.71	2.92	0.27	0.27	0.13	0.27	0.53
mesenchymal precursor cell - cardiac, donor4	11755-123G9	11.61	12.42	5.40	5.00	2.70	0.41	0.41	0.27	0.00	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	11.24	7.82	4.41	4.13	2.70	1.00	1.56	0.85	0.28	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	12.84	10.87	6.92	3.29	5.27	0.33	0.00	0.33	0.33	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	8.30	8.30	3.60	2.35	3.87	0.69	0.97	0.28	0.28	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	21.29	7.68	8.38	6.63	6.98	0.70	0.35	0.00	1.40	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	13.07	5.10	7.35	4.49	1.22	0.41	1.22	0.20	0.00	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	18.33	6.11	9.71	6.47	5.75	4.31	2.88	1.44	1.08	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	10.03	6.72	1.86	4.14	3.10	0.00	0.31	0.10	0.21	0.62
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	9.58	6.16	5.47	3.19	5.02	2.74	0.68	0.23	0.46	0.46
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	19.72	10.91	8.81	5.03	1.68	4.20	0.84	2.10	0.42	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	10.01	10.46	6.13	4.93	2.69	0.15	0.45	0.00	0.30	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	11.38	9.72	4.99	3.76	5.43	1.31	1.75	0.53	0.26	0.70
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	15.09	4.05	3.68	7.36	2.21	0.37	0.37	0.00	0.74	1.47
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	15.74	4.86	7.15	4.29	3.43	5.72	1.14	2.86	2.00	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	61.47	7.16	30.31	16.00	10.53	5.05	3.79	1.68	7.16	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.05	10.50	3.65	2.74	2.28	0.00	0.46	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	9.72	11.00	3.58	2.30	1.53	0.00	0.26	0.00	0.00	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	8.11	8.38	3.93	2.36	2.36	0.52	0.00	0.00	0.26	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	8.01	10.78	3.08	3.39	2.46	0.31	0.31	0.00	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	8.71	8.71	2.59	1.88	2.35	0.00	0.00	0.24	0.47	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	7.45	8.12	5.42	2.37	3.72	0.34	0.68	0.00	0.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	7.86	7.47	4.32	2.36	2.75	0.00	0.00	0.00	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	6.49	6.95	5.10	0.93	2.32	0.93	0.00	0.00	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	12.69	9.81	6.06	1.15	2.02	0.87	0.00	0.29	0.87	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	7.36	10.71	4.46	1.34	2.90	0.22	0.22	0.00	0.45	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	10.09	6.97	4.81	1.92	2.88	0.24	0.00	0.72	0.72	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	12.47	4.40	2.20	0.73	1.47	0.00	0.00	0.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	8.39	8.73	4.36	1.01	2.69	0.34	0.34	0.67	0.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	12.28	9.42	3.68	2.05	1.64	0.00	0.41	0.41	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	5.15	9.88	1.29	1.29	1.29	0.43	0.00	0.00	0.86	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	16.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	5.16	10.33	5.16	0.00	10.33	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	10.39	8.12	3.90	0.32	2.27	0.32	0.32	0.32	0.97	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	8.73	7.27	2.91	1.45	5.82	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	10.66	12.26	9.60	1.07	2.13	0.00	0.00	0.53	0.53	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	12.27	10.63	7.36	2.45	3.27	0.00	0.00	0.82	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	10.11	7.77	5.83	4.28	1.17	0.39	0.00	0.00	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	8.39	2.10	2.10	2.10	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	6.95	11.92	0.99	1.99	2.98	0.00	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	4.77	19.07	4.77	4.77	0.00	0.00	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	7.71	7.71	4.15	1.19	2.37	0.00	0.00	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	10.97	4.87	1.22	1.22	6.09	0.00	0.00	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	27.05	0.00	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	12.67	9.50	5.07	3.17	2.53	0.00	0.00	0.00	0.63	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	7.59	3.79	3.45	0.69	2.41	0.00	0.00	0.00	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	6.45	6.45	4.30	2.15	4.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	3.99	0.00	0.00	7.98	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	3.44	6.89	0.00	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	6.52	5.70	2.44	3.67	3.26	0.00	0.00	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	6.36	10.33	3.97	1.59	1.59	0.00	0.00	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	17.69	5.90	3.54	4.13	1.18	0.00	0.00	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	17.46	4.36	3.43	1.56	2.18	0.00	0.00	0.00	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	6.68	6.68	6.68	4.01	2.67	0.00	0.00	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	22.47	7.10	10.64	1.18	1.18	1.18	1.18	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	23.11	17.98	15.41	0.00	0.00	0.00	0.00	0.00	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	17.21	5.51	10.33	2.07	2.75	0.69	1.38	0.00	1.38	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	4.45	11.38	3.46	0.49	0.99	0.00	0.00	0.00	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	6.73	11.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	4.45	7.63	3.18	0.64	1.91	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	9.27	12.49	2.42	1.21	3.63	0.00	0.00	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	8.72	10.90	8.72	2.18	2.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	11.40	12.67	1.27	1.27	1.27	0.00	0.00	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	14.57	10.92	9.10	2.43	3.03	0.00	0.00	0.61	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	22.59	9.04	0.00	4.52	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	21.42	9.06	8.24	1.65	1.65	0.00	0.82	0.00	0.00	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	5.56	6.94	4.56	1.39	1.19	0.00	0.00	0.00	0.40	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	8.76	8.44	2.60	1.62	1.30	0.00	0.00	0.00	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	11.20	10.19	2.04	0.00	3.06	1.02	0.00	0.00	2.04	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	33.27	9.28	7.74	8.51	3.87	1.55	0.77	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	65.68	7.80	8.03	31.89	22.68	6.14	3.78	1.18	1.89	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	9.73	3.48	10.66	4.63	5.79	29.42	12.28	4.40	1.39	1.62
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	42.74	4.27	12.82	8.55	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	24.87	5.45	17.57	3.70	2.98	6.68	2.77	1.23	2.26	2.16
mesothelioma cell line:Mero-25	10850-111F4	20.43	4.54	14.53	4.54	2.50	17.48	10.67	1.82	1.13	4.54
mesothelioma cell line:Mero-41	10851-111F5	22.25	12.71	14.67	5.38	3.91	2.69	0.73	0.98	1.22	1.22
mesothelioma cell line:Mero-48a	10852-111F6	24.58	12.40	9.08	7.53	6.86	1.55	0.66	0.89	0.66	1.33
mesothelioma cell line:Mero-82	10853-111F7	31.27	4.20	24.97	4.73	4.73	9.72	4.20	1.58	1.31	0.79
mesothelioma cell line:Mero-83	10854-111F8	34.90	6.30	19.75	7.32	9.02	6.13	4.43	3.74	4.26	2.72
mesothelioma cell line:Mero-84	10855-111F9	18.45	4.30	10.87	3.79	7.58	8.34	4.55	2.27	0.25	1.01
mesothelioma cell line:Mero-95	10856-111G1	28.57	14.08	23.40	6.21	3.73	2.69	5.18	1.86	1.45	1.86
mesothelioma cell line:NCI-H2052	10847-111F1	42.41	8.12	36.77	10.10	22.03	13.91	8.12	2.82	5.63	2.98
mesothelioma cell line:NCI-H226	10846-111E9	11.76	4.34	16.29	3.26	5.43	15.57	8.33	1.27	0.90	1.63
mesothelioma cell line:NCI-H2452	10848-111F2	14.18	5.98	5.98	4.10	7.52	2.39	1.88	0.34	0.00	0.34
mesothelioma cell line:NCI-H28	10845-111E8	36.39	11.20	18.07	8.65	26.46	7.89	6.87	3.56	3.56	4.33
mesothelioma cell line:No36	10857-111G2	12.72	14.35	5.55	4.57	3.26	0.00	0.00	1.30	1.30	0.33
mesothelioma cell line:ONE58	10858-111G3	16.80	11.38	10.03	4.61	8.94	1.63	1.08	0.81	1.63	1.63
migratory langerhans cells, donor1	11901-125F2	5.37	6.33	1.34	1.15	0.58	17.85	0.77	5.57	0.77	0.00
migratory langerhans cells, donor2	11902-125F3	3.54	7.45	0.98	2.08	0.85	7.69	0.49	0.37	0.49	0.12
migratory langerhans cells, donor3	11903-125F4	8.62	7.36	2.69	3.05	1.26	18.67	1.97	1.26	2.15	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	4.90	10.45	0.65	4.57	2.61	0.33	0.98	1.31	0.33	2.61
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	26.28	4.87	4.87	13.35	8.27	1.91	3.18	0.21	2.76	2.54
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	174.38	8.29	40.31	25.34	16.59	13.36	21.19	5.99	10.37	2.30
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	7.04	7.04	3.04	2.28	6.66	72.69	1.90	29.31	1.52	1.33
myelodysplastic syndrome cell line:SKM-1	10772-110F7	3.70	35.11	0.92	2.96	4.07	0.00	0.00	0.00	0.00	0.74
myeloma cell line:PCM6	10474-106I6	9.69	13.44	0.99	5.93	3.76	0.00	0.59	0.00	0.20	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	24.86	6.09	5.07	11.67	4.57	0.00	1.52	0.00	2.03	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	29.62	18.83	5.49	10.00	19.81	0.00	0.20	0.20	0.20	1.18
nasal epithelial cells, donor1, tech_rep1	12226-129F3	49.92	9.69	11.25	16.05	7.24	2.79	4.68	0.67	5.79	1.34
nasal epithelial cells, donor1, tech_rep2	12226-129F3	38.90	7.87	9.63	9.78	6.03	3.75	5.00	1.32	6.84	1.47
nasal epithelial cells, donor2	12227-129F4	27.60	11.04	12.70	6.62	2.21	2.21	11.59	1.10	1.66	1.10
neuroblastoma cell line:CHP-134	10508-107D4	10.81	37.50	2.07	8.97	36.81	0.23	0.69	0.00	0.00	0.69
neuroblastoma cell line:NB-1	10539-107G8	5.80	58.18	1.68	5.24	5.24	0.00	0.19	0.00	0.00	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	6.33	16.45	0.84	5.27	10.97	0.00	0.42	0.00	0.00	0.84
neuroblastoma cell line:NH-12	10555-107I6	8.20	20.87	0.19	3.35	13.42	0.00	0.19	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	2.85	14.00	0.00	1.90	7.35	0.00	0.00	0.00	0.24	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	13.15	15.20	2.22	4.91	4.91	0.00	1.11	0.16	0.00	0.95
neuroectodermal tumor cell line:TASK1	10774-110F9	4.03	14.69	0.00	2.42	3.22	0.20	0.20	0.00	0.00	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	0.00	6.99	0.00	0.64	4.45	0.00	0.00	0.00	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	16.24	2.93	4.26	3.46	2.66	0.27	0.00	0.27	0.80	0.00
neutrophil PMN, donor1	12133-128D9	14.87	89.25	0.00	0.00	14.87	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	9.47	0.00	0.00	0.00	0.00	0.00	0.00	9.47	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	14.04	5.75	2.20	19.79	4.06	0.34	1.18	0.00	0.00	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	15.21	21.61	8.81	6.40	1.60	0.00	3.20	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	13.14	8.98	2.89	4.49	1.60	0.00	0.64	0.32	0.00	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	21.28	6.57	8.67	6.31	2.10	2.63	1.31	1.31	1.05	1.31
nucleus accumbens, adult, pool1	10037-101F1	23.72	56.34	10.97	5.91	7.22	0.84	1.31	0.28	0.47	0.75
occipital cortex - adult, donor10196	10172-103C1	26.78	35.03	6.18	8.24	4.12	4.12	2.06	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	66.55	26.57	15.57	9.12	18.79	1.61	2.42	2.15	0.00	2.95
occipital cortex, newborn, donor10223	10355-105E4	8.37	44.77	6.91	2.55	7.28	5.10	0.73	0.00	0.73	0.36
occipital lobe, adult, donor1	10076-102A4	18.63	56.42	6.82	3.15	4.99	0.79	0.26	0.26	0.00	1.05
occipital lobe, fetal, donor1	10073-102A1	19.31	27.03	3.43	9.01	20.17	0.86	0.43	0.00	0.00	0.00
occipital pole, adult, pool1	10036-101E9	21.68	62.21	10.80	6.23	5.68	0.47	1.89	0.24	0.08	0.63
olfactory region, adult	10195-103E6	17.39	38.78	7.07	4.97	7.26	0.38	0.96	0.38	0.19	1.15
optic nerve, donor1	10277-104E7	114.06	16.01	30.02	16.01	14.01	2.00	0.00	2.00	0.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	19.48	18.68	3.87	9.23	22.21	0.57	1.37	0.11	0.46	1.14
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	26.93	18.55	3.02	16.90	17.04	1.92	5.91	1.37	0.69	1.51
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	9.99	8.97	2.03	5.76	2.54	1.86	2.54	0.51	0.51	1.86
oral squamous cell carcinoma cell line:SAS	10544-107H4	22.06	8.20	6.58	8.09	5.43	0.81	3.12	0.46	0.81	1.39
osteoclastoma cell line:Hs 706.T	10704-109H2	29.98	7.94	9.99	7.94	5.88	0.59	0.29	0.29	2.35	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	6.54	8.41	1.87	7.47	8.41	0.00	0.00	0.00	0.93	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	4.67	15.90	0.64	2.54	3.39	0.00	0.00	0.00	0.00	0.21
ovary, adult, pool1	10020-101D2	13.36	8.47	3.67	3.49	2.88	1.57	0.26	0.35	0.26	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	10.27	8.62	0.73	5.13	3.30	0.18	0.18	0.00	0.00	0.00
pancreas, adult, donor1	10049-101G4	18.81	18.81	7.53	4.70	0.94	0.00	0.00	0.00	0.00	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	17.33	5.87	3.63	7.55	5.03	0.84	3.35	9.78	0.28	1.12
papillary adenocarcinoma cell line:8505C	10437-106E5	39.52	9.88	22.66	12.10	5.79	15.67	8.18	3.75	1.87	6.64
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	58.62	4.14	33.45	10.60	15.56	25.00	23.02	5.13	7.12	6.13
paracentral gyrus, adult, pool1	10035-101E8	21.78	58.57	10.89	5.67	9.06	1.28	1.19	0.27	0.55	0.73
parietal cortex, adult, donor10258	10373-105G4	6.61	37.43	5.87	0.00	4.40	0.00	0.00	0.00	0.00	0.73
parietal lobe - adult, donor10196	10171-103B9	27.27	57.37	10.35	8.46	8.46	0.94	0.94	0.00	0.00	3.76
parietal lobe, adult, donor10252	10157-103A4	36.20	36.20	12.83	6.84	12.83	0.29	1.14	1.14	0.29	2.28
parietal lobe, adult, pool1	10034-101E7	26.52	57.19	11.19	6.08	7.58	1.23	1.15	0.35	0.70	0.70
parietal lobe, fetal, donor1	10072-101I9	16.49	32.00	0.97	8.73	16.49	0.97	0.97	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	7.48	45.61	6.73	1.50	8.22	6.36	0.75	0.37	0.00	0.75
parotid gland, adult	10199-103F1	5.55	17.88	6.17	1.85	2.47	0.00	1.85	0.62	0.00	1.23
penis, adult	10200-103F2	13.43	9.67	5.91	1.07	1.61	0.54	0.00	1.07	0.00	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	18.04	22.31	0.74	2.97	5.21	0.00	0.00	0.19	0.00	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	22.58	12.53	12.82	11.51	4.81	5.83	8.89	1.31	1.60	1.46
pineal gland - adult, donor10196	10179-103C8	16.77	21.93	7.74	8.39	5.81	2.58	3.87	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	42.05	27.83	15.40	27.83	17.17	3.55	10.66	1.78	1.18	1.18
pineal gland, adult, donor10258	10377-105G8	20.69	26.96	13.80	8.78	7.52	2.51	1.88	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	17.20	18.21	9.11	7.08	2.02	8.09	1.01	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	34.40	28.14	8.86	15.64	15.64	6.78	5.73	1.04	1.04	2.08
pituitary gland, adult, donor10258	10378-105G9	6.81	25.54	4.26	4.26	5.11	0.85	0.85	0.00	0.85	0.00
placenta, adult, pool1	10021-101D3	26.77	18.38	9.57	8.49	4.52	2.15	1.51	6.13	1.51	0.65
plasma cell leukemia cell line:ARH-77	10840-111E3	2.38	6.36	0.26	1.85	1.85	3.05	1.06	0.26	0.00	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	28.02	7.94	7.63	8.72	3.58	1.40	0.78	0.31	0.31	1.09
pons, adult, pool1	10033-101E6	25.22	45.10	14.20	5.94	7.83	0.86	0.95	0.60	0.34	1.12
postcentral gyrus, adult, pool1	10032-101E5	22.93	63.38	12.03	6.54	9.59	0.61	1.31	0.35	0.44	0.96
promyelocytes/myelocytes PMC, donor1	12132-128D8	2.09	12.55	0.00	4.18	2.09	0.00	0.00	0.00	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	5.51	0.00	0.00	5.51	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	34.08	11.36	6.99	16.75	30.15	5.54	7.14	0.73	2.48	3.35
prostate cancer cell line:PC-3	10439-106E7	63.34	10.35	28.13	20.33	46.46	37.21	27.95	4.72	7.44	5.26
prostate, adult, pool1	10022-101D4	19.41	13.60	6.89	5.08	2.45	0.63	1.27	0.36	0.54	0.27
putamen, adult, donor10196	10176-103C5	24.08	52.41	6.14	8.26	9.68	2.12	1.89	0.47	0.24	0.94
putamen, adult, donor10252	10152-102I8	21.57	35.29	5.88	3.92	3.92	0.00	0.00	0.00	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	4.37	25.13	4.37	2.19	4.37	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	5.07	40.11	5.80	2.90	3.38	1.21	0.24	0.00	0.24	0.48
putamen, newborn, donor10223	10365-105F5	8.25	21.74	14.24	0.00	3.00	0.75	0.00	0.00	0.00	2.25
rectal cancer cell line:TT1TKB	10469-106I1	26.77	4.95	4.65	8.73	12.80	5.24	4.36	1.45	0.87	4.65
rectum, fetal, donor1	10067-101I4	22.26	2.78	4.17	11.13	6.95	0.00	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	86.07	15.26	34.77	22.05	14.42	5.09	6.15	1.48	2.54	2.97
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	59.23	3.73	3.73	18.23	7.46	17.40	2.07	2.49	1.66	0.83
retina, adult, pool1	10030-101E3	48.01	22.36	21.87	8.65	8.15	3.78	3.98	0.89	1.39	2.19
retinoblastoma cell line:Y79	10475-106I7	33.25	14.29	3.90	12.99	98.21	9.35	14.29	4.42	2.86	3.38
rhabdomyosarcoma cell line:KYM-1	10787-110H4	4.79	11.56	0.61	2.34	7.50	0.00	0.12	0.12	0.00	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	10.69	7.31	0.84	2.81	8.44	0.00	0.00	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	5.30	8.34	0.76	1.52	5.30	0.00	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	26.38	6.64	7.61	2.91	4.69	0.97	2.43	0.49	0.65	0.32
salivary acinar cells, donor2	11772-123I8	24.51	9.64	4.82	3.17	3.17	0.14	0.83	0.28	0.55	1.38
salivary acinar cells, donor3	11773-123I9	45.02	7.28	8.61	5.96	5.30	0.66	0.00	0.00	0.66	0.66
salivary gland, adult, pool1	10093-102C3	16.01	20.02	9.72	2.86	0.57	1.14	0.00	0.00	0.57	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	47.30	11.47	21.84	14.08	19.90	7.17	3.79	2.61	4.22	2.78
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	50.08	11.17	22.33	14.69	19.28	6.47	5.88	2.00	3.06	2.70
seminal vesicle, adult	10201-103F3	8.99	13.76	5.82	6.88	1.59	0.00	0.53	0.53	0.00	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	14.09	4.86	7.04	3.40	2.43	12.39	9.96	2.67	0.49	2.67
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	17.61	9.31	7.55	8.30	4.28	0.50	0.75	0.75	2.01	0.75
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	20.07	13.05	19.07	9.03	15.05	6.02	4.01	1.00	1.00	5.02
serous cystadenocarcinoma cell line:HTOA	10693-109F9	67.29	12.63	22.57	12.89	19.48	14.10	11.55	2.82	3.22	3.63
signet ring carcinoma cell line:Kato III	10436-106E4	115.61	22.33	37.47	21.44	15.92	18.79	12.71	7.63	9.28	11.27
signet ring carcinoma cell line:NUGC-4	10483-107A6	51.22	6.45	22.32	13.16	18.32	10.32	7.61	2.19	7.48	2.97
skeletal muscle - soleus muscle, donor1	10282-104F3	17.02	5.67	7.09	1.42	3.55	1.42	0.00	0.71	0.71	0.71
skeletal muscle, adult, pool1	10023-101D5	23.75	7.56	9.48	3.60	1.68	2.16	1.44	0.24	0.12	0.96
skeletal muscle, fetal, donor1	10066-101I3	52.26	3.02	10.05	7.04	5.03	3.02	0.00	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	33.93	27.14	6.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	22.09	17.04	11.99	3.16	4.42	1.26	0.63	1.26	2.52	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	26.68	7.34	3.34	14.01	19.34	2.33	12.67	0.67	0.00	1.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	31.21	24.90	4.10	8.83	27.42	0.00	3.15	0.32	0.32	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	0.96	10.02	0.00	1.93	1.54	0.00	0.39	0.00	0.19	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	12.69	9.72	2.31	4.94	37.75	2.14	4.12	0.82	0.16	0.99
small cell lung carcinoma cell line:NCI-H82	10842-111E5	18.34	11.26	0.97	10.94	8.69	0.16	2.09	0.32	0.16	0.97
small cell lung carcinoma cell line:WA-hT	10562-108A4	13.29	10.46	3.92	8.72	11.33	0.87	6.10	0.22	0.00	1.74
small intestine, adult, pool1	10024-101D6	41.57	28.79	12.42	17.68	3.46	5.26	0.60	1.91	0.96	2.27
small intestine, fetal, donor1	10064-101I1	23.83	11.06	2.46	7.86	1.47	2.21	0.49	0.25	0.00	1.47
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	26.16	16.93	17.95	8.21	5.64	1.54	6.15	1.54	0.00	2.56
smooth muscle, adult, pool1	10048-101G3	14.22	13.44	2.58	2.33	2.07	0.26	0.26	0.26	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	12.33	19.03	3.48	1.88	4.02	0.27	1.61	0.27	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	49.32	14.45	13.76	8.49	9.18	2.52	1.15	0.69	1.15	1.84
spinal cord, adult, donor10252	10159-103A6	69.39	9.86	15.38	11.43	12.22	2.37	0.79	1.18	0.79	3.15
spinal cord, adult, donor10258	10369-105F9	17.29	11.76	8.30	0.69	2.77	0.00	0.00	1.38	0.69	4.15
spinal cord, fetal, donor1	10056-101H2	27.44	12.20	7.93	9.76	6.71	0.00	1.22	0.61	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	15.15	11.94	22.50	3.67	4.59	2.30	0.00	0.92	0.46	1.38
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	21.06	5.23	7.62	5.82	3.88	0.15	0.15	0.45	0.00	0.30
spleen, adult, pool1	10025-101D7	14.10	6.94	11.56	6.61	4.74	4.52	1.76	0.66	1.21	0.88
spleen, fetal, pool1	10044-101F8	76.20	10.57	17.88	25.27	13.90	15.73	2.86	11.44	8.02	1.51
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	6.00	7.97	1.45	1.76	5.59	15.01	6.00	2.69	1.45	0.72
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	24.87	15.19	7.97	12.15	7.22	1.52	1.90	0.19	0.19	0.95
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	32.85	27.61	10.13	14.68	8.74	0.70	4.54	5.94	2.10	4.54
squamous cell carcinoma cell line:T3M-5	10616-108G4	102.03	7.04	34.40	17.98	20.72	14.46	17.59	10.16	6.25	13.29
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	72.15	27.35	16.32	31.52	11.59	4.61	5.40	6.42	6.98	5.52
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	4.24	25.84	0.00	5.93	2.12	0.00	0.42	0.00	0.00	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	13.96	2.12	4.65	4.65	3.38	0.00	0.00	0.00	0.00	1.27
stomach, fetal, donor1	10062-101H8	59.81	9.61	13.88	9.61	7.48	1.07	1.07	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	14.24	10.82	6.84	1.14	1.14	1.14	1.14	0.57	2.28	1.14
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	93.68	11.84	22.22	11.63	17.24	1.25	1.45	1.45	2.08	2.70
substantia nigra, adult, donor10258	10371-105G2	9.31	27.93	4.66	2.59	4.14	1.03	0.00	0.00	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	18.37	12.72	15.54	5.65	11.31	0.71	0.00	0.00	0.71	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	6.42	22.24	0.23	4.36	5.96	0.00	0.00	0.23	0.00	0.69
temporal lobe, adult, pool1	10031-101E4	27.55	61.80	15.68	6.44	11.53	0.93	0.93	0.59	0.51	1.44
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	23.50	34.90	2.85	10.68	17.09	0.00	0.00	0.00	1.42	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	14.07	31.21	2.20	6.59	21.54	0.00	0.00	1.32	0.88	1.32
tenocyte, donor1	11763-123H8	25.48	8.03	5.59	4.54	3.14	0.35	0.35	0.35	0.70	1.75
tenocyte, donor2	11765-123I1	21.75	9.16	5.34	3.05	1.91	0.00	0.00	0.00	1.14	0.38
tenocyte, donor3	11768-123I4	20.39	8.53	4.82	4.45	1.11	1.11	0.00	0.00	0.00	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	4.25	10.88	1.02	4.08	3.40	0.17	1.70	0.34	0.00	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	29.60	14.95	3.39	9.56	9.87	0.00	0.31	0.31	0.00	1.23
teratocarcinoma cell line:PA-1	10807-111A6	19.37	7.75	3.87	4.80	4.03	0.77	6.66	0.31	0.00	1.08
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	20.95	15.36	8.00	6.98	3.94	9.39	21.83	5.84	0.89	1.78
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	17.77	17.77	4.16	4.92	7.56	13.61	25.72	4.16	0.38	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	72.85	32.50	22.03	16.25	7.09	21.27	63.26	17.12	1.42	3.71
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	11.73	5.21	6.51	5.86	3.91	17.26	22.15	3.26	0.33	3.58
testis, adult, pool1	10026-101D8	16.32	17.39	7.52	3.11	32.64	1.50	1.61	0.21	0.00	0.75
testis, adult, pool2	10096-102C6	4.06	26.16	4.51	0.45	106.00	0.90	0.90	0.90	0.45	1.35
thalamus - adult, donor10196	10168-103B6	55.20	29.81	7.73	11.04	8.83	6.62	2.21	0.00	0.00	1.10
thalamus, adult, donor10252	10154-103A1	87.67	17.82	20.94	9.22	14.85	1.88	1.09	0.94	0.63	2.34
thalamus, adult, donor10258, tech_rep1	10370-105G1	9.24	21.55	7.70	4.62	9.24	0.00	0.00	3.08	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	12.68	20.26	4.94	3.29	1.98	0.66	0.49	0.33	0.00	0.82
thalamus, newborn, donor10223	10366-105F6	4.60	24.74	2.30	2.30	4.03	0.58	0.58	0.58	1.15	0.00
throat, adult	10209-103G2	14.48	8.74	9.99	3.75	1.75	2.50	0.50	0.25	1.75	0.25
throat, fetal, donor1	10061-101H7	34.43	14.32	11.88	7.62	2.74	2.13	1.83	0.91	0.61	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	2.19	21.26	0.20	1.59	2.19	0.00	0.00	0.00	0.00	0.40
thymus, adult, pool1	10027-101D9	40.76	17.80	12.33	14.51	21.18	27.64	45.73	4.18	0.89	10.44
thymus, fetal, pool1	10043-101F7	43.85	16.94	11.53	15.79	23.27	26.08	40.73	4.16	0.73	6.96
thyroid carcinoma cell line:KHM-5M	10776-110G2	18.61	11.43	6.91	11.43	5.45	0.66	0.66	0.40	0.40	0.80
thyroid carcinoma cell line:TCO-1	10783-110G9	96.67	4.61	26.96	16.76	6.15	4.47	3.21	2.51	2.79	3.07
thyroid, adult, pool1	10028-101E1	35.27	22.95	8.40	13.90	4.29	1.87	1.68	1.21	1.03	1.12
thyroid, fetal, donor1	10060-101H6	14.50	20.30	4.75	5.54	2.37	0.53	0.79	0.53	0.00	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	40.04	9.24	12.32	0.00	0.00	0.00	0.00	0.00	3.08	0.00
tongue, adult	10203-103F5	12.79	12.33	9.30	3.49	2.56	0.93	0.47	0.70	0.23	1.40
tongue, fetal, donor1	10059-101H5	20.89	13.40	3.55	4.34	1.18	0.79	1.58	0.39	0.00	1.97
tonsil, adult, pool1	10047-101G2	18.63	20.94	12.72	6.21	4.01	7.61	4.61	1.00	0.70	0.90
trachea, adult, pool1	10029-101E2	22.58	13.01	14.07	5.89	4.99	3.60	3.19	0.33	1.31	0.74
trachea, fetal, donor1	10058-101H4	29.62	10.39	12.31	6.54	3.08	2.31	1.15	1.92	0.38	1.92
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	21.61	8.15	9.21	6.38	2.48	0.71	0.35	0.35	1.42	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	16.82	14.29	6.48	5.47	16.31	10.94	10.03	2.03	0.71	3.75
transitional-cell carcinoma cell line:JMSU1	10492-107B6	26.95	7.68	8.77	8.77	9.56	3.45	2.19	0.47	1.25	1.57
tridermal teratoma cell line:HGRT	10694-109G1	20.93	0.00	0.00	5.71	3.81	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	120.54	13.88	42.92	17.61	13.29	9.14	12.11	3.22	6.69	3.81
umbilical cord, fetal, donor1	10057-101H3	33.38	4.17	8.35	14.61	4.17	0.00	4.17	2.09	2.09	0.00
uterus, adult, pool1	10100-102D1	16.72	13.48	8.19	4.10	1.88	1.54	0.17	0.68	0.34	0.17
uterus, fetal, donor1	10055-101H1	22.01	15.87	8.19	8.19	4.10	1.02	1.02	0.00	0.51	0.51
vagina, adult	10204-103F6	24.56	5.82	6.46	10.99	11.63	0.00	0.00	0.65	0.00	0.00
vein, adult	10191-103E2	16.88	7.89	9.43	3.07	3.29	3.51	5.70	0.44	0.44	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	2.14	9.35	0.27	1.07	3.20	14.69	7.48	5.07	1.07	1.07